Online citations, reference lists, and bibliographies.
← Back to Search

Management Guidelines For Children With Thyroid Nodules And Differentiated Thyroid Cancer.

G. Francis, S. Waguespack, A. Bauer, P. Angelos, S. Benvenga, J. Cerutti, C. Dinauer, J. Hamilton, I. Hay, M. Luster, M. Parisi, M. Rachmiel, G. Thompson, S. Yamashita
Published 2015 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
BACKGROUND Previous guidelines for the management of thyroid nodules and cancers were geared toward adults. Compared with thyroid neoplasms in adults, however, those in the pediatric population exhibit differences in pathophysiology, clinical presentation, and long-term outcomes. Furthermore, therapy that may be recommended for an adult may not be appropriate for a child who is at low risk for death but at higher risk for long-term harm from overly aggressive treatment. For these reasons, unique guidelines for children and adolescents with thyroid tumors are needed. METHODS A task force commissioned by the American Thyroid Association (ATA) developed a series of clinically relevant questions pertaining to the management of children with thyroid nodules and differentiated thyroid cancer (DTC). Using an extensive literature search, primarily focused on studies that included subjects ≤18 years of age, the task force identified and reviewed relevant articles through April 2014. Recommendations were made based upon scientific evidence and expert opinion and were graded using a modified schema from the United States Preventive Services Task Force. RESULTS These inaugural guidelines provide recommendations for the evaluation and management of thyroid nodules in children and adolescents, including the role and interpretation of ultrasound, fine-needle aspiration cytology, and the management of benign nodules. Recommendations for the evaluation, treatment, and follow-up of children and adolescents with DTC are outlined and include preoperative staging, surgical management, postoperative staging, the role of radioactive iodine therapy, and goals for thyrotropin suppression. Management algorithms are proposed and separate recommendations for papillary and follicular thyroid cancers are provided. CONCLUSIONS In response to our charge as an independent task force appointed by the ATA, we developed recommendations based on scientific evidence and expert opinion for the management of thyroid nodules and DTC in children and adolescents. In our opinion, these represent the current optimal care for children and adolescents with these conditions.
This paper references
Pathological report of a case of acromegaly with especial reference to the lesions in the hypophysis cerebri and in the thyroid gland ; and a case of hemorrhage into the pituitary
P. Bailey (1898)
10.2307/j.ctvzgb86t.9
Cancer
Z. Hall (1906)
10.1201/b13358-72
[Thyroid cancer].
P. Desaive (1951)
10.1210/JCEM-12-2-191
The iodine-deficient human thyroid gland; a preliminary report.
J. Stanbury (1952)
Yaciofano AC 1952 The iodine-deficient human thyroid gland; a preliminary report. The Journal of clinical endocrinology and metabolism 12:191-207
JB Stanbury (1952)
10.1097/00000446-195604000-00026
Cancer; a review.
M. Knapp (1956)
The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.
R. Benua (1962)
Acromegaly: a review of 100 cases.
D. Gordon (1962)
STRUCTURAL CHANGES IN THE THYROID GLANDS OF HEALTHY YOUNG MEN.
J. Oertel (1965)
[THYROID CANCER IN CHILDREN].
C. Dufourmentel (1965)
STRUCTURAL CHANGES IN THE THYROID GLANDS OF HEALTHY YOUNG MEN.
Oertel Je (1965)
10.1210/JCEM-27-10-1418
Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment.
P. Sönksen (1967)
10.1136/bmj.4.5634.797
Calcium Metabolism in Acromegaly
A. Nadarajah (1968)
10.1001/JAMA.1969.03150180023004
A glucose-responsive insulinoma.
L. Power (1969)
10.1126/science.182.4108.171
Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect
J. Gerich (1973)
10.1210/JCEM-36-2-207
Source of Estrogen Production in Postmenopausal Women
J. Grodin (1973)
10.1017/S0021932000008956
Menopausal age and symptomatology in a general practice.
B. Thompson (1973)
10.1093/OXFORDJOURNALS.QJMED.A067396
Clinical and laboratory study of acromegaly: assessment before and one year after treatment.
J. Kanis (1974)
10.1016/0002-9343(74)90009-6
Suppressive therapy of nontoxic goiter.
K. Shimaoka (1974)
10.1001/ARCHINTE.1974.00320200146022
Factitial hypoglycemia. Three cases diagnosed on the basis of insulin antibodies.
F. J. Service (1974)
Suppressive therapy of nontoxic goiter. The American journal of medicine 57:576-583
K Shimaoka (1974)
Estriol prevention of mammary carcinoma induced by 7,12-dimethylbenzanthracene and procarbazine.
H. Lemon (1975)
10.1001/JAMA.1975.03240160024021
Clofibrate and niacin in coronary heart disease.
J. Stamler (1975)
10.1016/0026-0495(75)90129-8
Serum lipids in acromegaly.
E. Nikkilä (1975)
Insulinoma: clinical and diagnostic features of 60 consecutive cases.
Dale Aj (1976)
10.1111/j.1471-0528.1977.tb12491.x
ENDOCRINE CHANGES AND SYMPTOMATOLOGY AFTER OOPHORECTOMY IN PREMENOPAUSAL WOMEN
S. Chakravarti (1977)
10.1056/NEJM197711102971903
Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies.
J. A. Scarlett (1977)
10.1016/0002-9343(77)90122-X
Pituitary apoplexy. Association of degenerative change in pituitary ademona with radiotherapy and detection by cerebral computed tomography.
L. Weisberg (1977)
10.1210/JCEM-47-1-126
Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies.
A. Schneider (1978)
10.1016/S0140-6736(79)90346-5
Acromegaly and narcolepsy.
P. Rees (1979)
10.1056/NEJM197911223012102
Evaluation of acromegaly by radioimmunoassay of somatomedin-C.
D. Clemmons (1979)
10.1210/JCEM-49-3-484
Acromegaly and vitamin D metabolism: effect of bromocriptine treatment.
P. Eskildsen (1979)
Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers.
J. Němec (1979)
10.1001/JAMA.1979.03300240039024
Systemic absorption and sustained effects of vaginal estrogen creams.
P. L. Martin (1979)
10.1001/JAMA.1980.03310160041024
Bromocriptine for an acromegalic patient. Improvement in cardiac function and carpal tunnel syndrome.
R. Luboshitzky (1980)
Clonidine (Dixarit) for menopausal flushing.
R. Edington (1980)
10.1016/0002-9343(80)90470-2
Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status.
D. Clemmons (1980)
10.1001/ARCHINTE.1980.00330160107039
Myxomatous degeneration and cystic medial necrosis associated with acromegaly.
S. Ondreyco (1980)
10.1001/JAMA.1980.03310130021021
Oral medroxyprogesterone in the treatment of postmenopausal symptoms.
I. Schiff (1980)
10.1530/ACTA.0.0960444
Calcium and vitamin D metabolism in acromegaly.
B. Lund (1981)
10.1056/NEJM198111123052007
Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones.
G. Boden (1981)
10.2337/diab.30.5.377
Pathogenesis of Hypoglycemia in Insulinoma Patients: Suppression of Hepatic Glucose Production by Insulin
R. Rizza (1981)
Effect of Clonidine on Hot Flashes in Postmenopausal Women
L. Laufer (1982)
10.1001/ARCHINTE.1982.00340230060013
Histochemical characterization of the cutaneous involvement of acromegaly.
L. Matsuoka (1982)
10.1093/OXFORDJOURNALS.QJMED.A067716
The Acromegaly Syndrome
A. Jadresic (1982)
10.1210/JCEM-55-5-858
Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies.
D. Wilson (1982)
10.1172/JCI110570
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.
E. Seeman (1982)
10.3109/00016348209156584
Effect of Oral Medroxyprogesterone Acetate on Menopausal Symptoms in Patients with Endometrial Carcinoma
K. Aslaksen (1982)
10.1016/0090-3019(83)90208-2
Coincidental pituitary adenoma and cerebral aneurysm with pathological findings.
J. Mangiardi (1983)
10.1056/NEJM198303033080903
Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.
N. White (1983)
Oral glucose tolerance test compared with a mixed meal in the diagnosis of reactive hypoglycemia. A caveat on stimulation.
Hogan Mj (1983)
10.2337/diab.32.2.134
Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion
G. Bolli (1983)
10.1016/S0002-9394(14)77788-8
Visual status after transsphenoidal surgery at the Mayo Clinic, 1971-1982.
J. Trautmann (1983)
10.1136/jcp.37.6.651
Hyperinsulinaemic hypoglycaemia due to chlorpropamide-induced nesidioblastosis.
G. Rayman (1984)
10.2337/diab.33.8.732
A Reliable and Reproducible Test for Adequate Glucose Counterregulation in Type I Diabetes Mellitus
G. Bolli (1984)
10.1056/NEJM198512193132504
Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
S. Lamberts (1985)
10.1210/JCEM-61-1-7
Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy.
S. Takamoto (1985)
10.1111/j.1365-2265.1985.tb03243.x
NEUROENDOCRINOLOGY OF MENOPAUSAL FLUSHES: AN HYPOTHESIS OF FLUSH MECHANISM
R. Casper (1985)
10.1007/BF03348564
Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo
U. Feldt-Rasmussen (1985)
Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma.
D. van Nostrand (1986)
10.1097/00000478-198604000-00003
Risk Factors in Follicular Thyroid Carcinomas: A Retrospective Follow-up Study Covering a 14-Year Period with Emphasis on Morphological Findings
W. Lang (1986)
10.1016/S0735-1097(86)80293-5
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.
P. Canner (1986)
10.1259/0007-1285-59-697-45
The long-term hazards of the treatment of thyroid cancer with radioiodine.
C. Edmonds (1986)
Acromegalic arthropathy: a reversible rheumatic disease.
S. Lacks (1986)
10.1259/0007-1285-59-702-583
Oedema of the neck after ablation of the thyroid with radioactive iodine.
A. Goolden (1986)
10.1016/S0140-6736(86)91405-4
RAPID IMPROVEMENT IN SLEEP APNOEA OF ACROMEGALY AFTER SHORT-TERM TREATMENT WITH SOMATOSTATIN ANALOGUE SMS 201-995
P. Chanson (1986)
10.1210/JCEM-62-6-1173
Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
B. Arafah (1986)
10.14219/JADA.ARCHIVE.1987.0127
Acromegaly and resulting myofascial pain and temporomandibular joint dysfunction: review of the literature and report of case.
R. E. Hampton (1987)
10.1111/j.1365-2265.1987.tb02947.x
SLEEP APNOEA AND DAYTIME SLEEPINESS IN ACROMEGALY: RELATIONSHIP TO ENDOCRINOLOGICAL FACTORS
T. Pekkarinen (1987)
10.1016/0002-9378(87)90050-0
Treatment of menopausal hot flashes with transdermal administration of clonidine.
M. Nagamani (1987)
10.1210/JCEM-65-6-1088
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients.
M. Schlumberger (1987)
10.1056/NEJM198711123172001
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
M. Frick (1987)
Autonomously functioning thyroid nodules in childhood and adolescence.
R. Croom (1987)
10.1016/0002-9343(87)90692-9
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
J. Crouse (1987)
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. The Journal of clinical endocrinology and metabolism 65:1088-1094
M Schlumberger (1987)
10.1001/JAMA.1988.03410130125037
Low-density lipoprotein subclass patterns and risk of myocardial infarction.
M. Austin (1988)
Recurrence and morbidity in differentiated thyroid carcinoma in children.
M. La Quaglia (1988)
Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades.
D. Zimmerman (1988)
10.1210/JCEM-66-6-1171
The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant.
F. Frankenne (1988)
10.7326/0003-4819-108-2-252
Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up.
G. Grunberger (1988)
10.2337/diab.37.1.81
Correlation Between Minimal Secretory Capacity of Pancreatic β-Cells and Stability of Diabetic Control
M. Fukuda (1988)
Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.
M. Schlumberger (1988)
10.2337/diab.37.12.1595
Role of Insulin Resistance in Human Disease
G. Reaven (1988)
10.1016/0002-9378(88)90230-X
Veralipride: alternative antidopaminergic treatment for menopausal symptoms.
A. David (1988)
Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104:11571166
D Zimmerman (1988)
Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104:1157–1166
D Zimmerman (1988)
10.7326/0003-4819-110-1-35
NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
P. Gorden (1989)
10.1056/NEJM198903303201304
Recurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions.
L. Fogelfeld (1989)
10.1136/bmj.298.6668.227
Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.
P. Dodson (1989)
10.1093/OXFORDJOURNALS.QJMED.A068308
Hypopituitarism following external radiotherapy for pituitary tumours in adults.
M. Littley (1989)
10.1056/NEJM198905043201804
Increased blood pressure during potassium depletion in normotensive men.
G. G. Krishna (1989)
10.1530/ACTA.0.1230603
On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules.
M. Celani (1990)
10.3322/CANJCLIN.40.5.299
Radioactive iodine therapy: Effect on functioning metastases ofadenocarcinoma of the thyroid
S. M. Seidlin (1990)
10.1210/JCEM-70-3-771
Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly.
N. Hattori (1990)
10.1210/JCEM-71-2-414
Natural history, treatment, and course of papillary thyroid carcinoma.
L. Degroot (1990)
10.1007/BF03349537
Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201–995 and bromocriptine
M. Montini (1990)
10.1016/S0002-9610(05)80538-0
Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients.
R. Frankenthaler (1990)
10.3109/00016349009013303
Does Physical Exercise Influence the Frequency of Postmenopausal Hot Flushes?
M. Hammar (1990)
10.1210/JCEM-71-3-725
Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.
A. Beckers (1990)
10.7326/0003-4819-115-2-77
Potassium depletion exacerbates essential hypertension.
G. G. Krishna (1991)
10.2337/diab.40.2.223
Reduced Neuroendocrine and Symptomatic Responses to Subsequent Hypoglycemia After 1 Episode of Hypoglycemia in Nondiabetic Humans
S. Heller (1991)
10.1016/S1010-5182(05)80274-4
Typical changes in the viscerocranium in acromegaly.
A. Künzler (1991)
10.1148/RADIOLOGY.178.1.1984311
Insulinomas: localization with selective intraarterial injection of calcium.
J. Doppman (1991)
10.1016/S0025-6196(12)62083-7
Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.
F. J. Service (1991)
Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group.
M. Tucker (1991)
10.1111/j.1464-5491.1991.tb01516.x
Unexplained Deaths of Type 1 Diabetic Patients
R. Tattersall (1991)
10.1002/1097-0142(19910415)67:8<2186::AID-CNCR2820670830>3.0.CO;2-0
Differentiated thyroid carcinomas in children and adolescents
A. M. Samuel (1991)
10.5555/URI:PII:003960609290318T
Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy.
J. V. van Heerden (1992)
10.1016/0306-4565(92)90018-B
MODULATION OF MENOPAUSAL HOT FLASHES BY AMBIENT TEMPERATURE
F. Kronenberg (1992)
10.1136/bmj.304.6838.1343
Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
M. Brada (1992)
10.1161/01.CIR.85.1.37
Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment
Vesa Manninen (1992)
Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients.
H. Maxon (1992)
10.2337/diab.41.10.1335
Further Defects in Counterregulatory Responses Induced by Recurrent Hypoglycemia in IDDM
M. Davis (1992)
10.1016/0145-2126(92)90160-9
Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines.
T. Baier (1992)
10.1210/JCEM.74.5.1569148
Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy.
N. Møller (1992)
10.1016/0360-3016(92)90686-C
Reirradiation of pituitary adenoma
R. Schoenthaler (1992)
10.1093/OXFORDJOURNALS.EURHEARTJ.A060047
Arrhythmia profile in acromegaly.
G. Kahaly (1992)
10.2337/diacare.16.8.1131
Alanine and Terbutaline in Treatment of Hypoglycemia in IDDM
B. V. Wiethop (1993)
10.1159/000288641
Psychosomatic view of endocrine disorders.
G. Fava (1993)
10.2337/diab.42.11.1683
Meticulous Prevention of Hypoglycemia Normalizes the Glycemic Thresholds and Magnitude of Most of Neuroendocrine Responses to, Symptoms of, and Cognitive Function During Hypoglycemia in Intensively Treated Patients With Short-Term IDDM
C. Fanelli (1993)
10.1210/JCEM.76.3.8445035
Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
P. Boyle (1993)
10.1097/00006123-199310000-00007
A retrospective analysis of pituitary apoplexy.
D. Bills (1993)
10.1172/JCI116302
Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
S. Dagogo-Jack (1993)
MR of the pituitary gland postsurgery: serial MR studies following transsphenoidal resection.
T. Dina (1993)
10.1016/0002-9149(93)90161-5
Long-term echocardiographic follow-up of acromegalic heart disease.
J. Hradec (1993)
10.1056/NEJM199309303291401
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long‐Term Complications in Insulin‐Dependent Diabetes Mellitus
D. Nathan (1993)
10.1056/NEJM199302253280807
Management of a solitary thyroid nodule.
E. Mazzaferri (1993)
10.3171/JNS.1993.79.1.0070
Results of surgical treatment for growth hormone-secreting pituitary adenomas.
D. Davis (1993)
10.1002/1097-0142(19930215)71:4<1348::AID-CNCR2820710429>3.0.CO;2-3
Pulmonary metastases in children and young adults with differentiated thyroid cancer
R. Vassilopoulou-sellin (1993)
10.1093/OXFORDJOURNALS.QJMED.A068816
An audit of outcome of treatment in acromegaly.
A. Bates (1993)
10.1002/1097-0142(19931001)72:7<2227::AID-CNCR2820720727>3.0.CO;2-I
Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk
R. Tsang (1993)
10.1016/0360-3016(92)90941-A
Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors.
R. Tsang (1994)
10.1016/S0140-6736(94)91998-4
ITT and IGF-I in the diagnosis of growth hormone deficiency in adults
D. Hoffman (1994)
10.2337/diab.43.12.1426
Reversal of Hypoglycemia Unawareness, But Not Defective Glucose Counterregulation, in IDDM
S. Dagogo-Jack (1994)
10.1016/S0140-6736(94)91336-6
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes
I. Cranston (1994)
10.5981/jjhnc1974.19.316
[Thyroid carcinoma].
F. Iida (1994)
10.2337/diacare.17.7.697
Frequency of Severe Hypoglycemia in Patients With Type I Diabetes With Impaired Awareness of Hypoglycemia
A. Gold (1994)
Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine.
F. Pacini (1994)
10.7326/0003-4819-121-12-199412150-00004
The Efficacy of Acarbose in the Treatment of Patients with NonInsulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial
J. Chiasson (1994)
10.1056/NEJM199408113310602
Megestrol acetate for the prevention of hot flashes.
C. Loprinzi (1994)
Blood supply of the parathyroid gland from the superior thyroid artery.
M. Nobori (1994)
10.1210/JCEM.78.6.8200931
Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women.
I. Chapman (1994)
10.1089/THY.1994.4.199
Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma.
A. Kumar (1994)
10.1136/bmj.309.6952.436
Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension
J. Geleijnse (1994)
10.1530/EJE.0.1300350
Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.
J. Faber (1994)
10.2307/3579122
Chromosome aberrations after treatment with radioactive iodine for thyroid cancer.
L. Baugnet-Mahieu (1994)
10.2337/diab.43.2.313
Mortality and Treatment Side-Effects During Long-Term Intensified Conventional Insulin Treatment in the Stockholm Diabetes Intervention Study
P. Reichard (1994)
10.1089/THY.1995.5.165
Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma.
B. Schaadt (1995)
10.1038/bjc.1995.410
Childhood thyroid cancer in England and Wales.
H. R. Harach (1995)
10.1126/SCIENCE.7618077
Epidemiology faces its limits.
G. Taubes (1995)
10.1016/S0889-8529(18)30019-7
Evaluation and management of the solid thyroid nodule.
H. Burch (1995)
10.1056/NEJM199511163332001
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
J. Shepherd (1995)
10.3171/JNS.1995.83.2.0363
Delayed hyponatremia after transsphenoidal surgery for pituitary adenoma. Report of nine cases.
D. Kelly (1995)
10.1200/JCO.1995.13.11.2737
Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy.
R. Couzi (1995)
10.1016/0168-8227(95)01064-K
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Y. Ohkubo (1995)
Calcium intake and blood pressure: epidemiology revisited.
Morris Cd (1995)
10.2307/3579003
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies.
E. Ron (1995)
10.1210/JCEM.80.11.7593429
The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients.
B. Delhougne (1995)
10.1093/OXFORDJOURNALS.ANNONC.A059224
Feasibility of the association of mitotane with etoposide, adriamycin and cisplatin combination chemotherapy in advanced adrenocortical cancer patients. Report on 7 cases.
A. Pia (1995)
10.1001/JAMA.1995.03520390045031
Variation in Patient Utilities for Outcomes of the Management of Chronic Stable Angina: Implications for Clinical Practice Guidelines
R. Nease (1995)
10.1089/THY.1995.5.365
Childhood thyroid diseases around Chernobyl evaluated by ultrasound examination and fine needle aspiration cytology.
M. Ito (1995)
10.1530/EJE.0.1330686
In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide.
S. Ezzat (1995)
10.1056/NEJM199508313330918
Maternal-fetal transfer of octreotide.
P. Caron (1995)
Evaluation and management of the solid thyroid nodule. Endocrinology and metabolism clinics of North America 24:663-710
HB Burch (1995)
10.1007/978-3-7091-9450-8_13
LINAC-radiosurgery (LINAC-RS) in pituitary adenomas: preliminary results.
J. Voges (1996)
10.1210/JCEM.81.6.8964877
Prediction of efficacy of octreotide therapy in patients with acromegaly.
A. Colao (1996)
10.1001/JAMA.276.16.1322
Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.
C. Saudek (1996)
10.1210/JCEM.81.5.8626847
Insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children with nephrotic syndrome.
D. Y. Lee (1996)
10.1016/S0889-8529(05)70311-X
Thyroid cancer in children, pregnant women, and patients with Graves' disease.
D. McClellan (1996)
Serum levels of sex hormones, thyroid hormones, growth hormone, IGF I, and cortisol and their relations to body fat distribution in healthy women dependent on their menopausal status.
S. Kirchengast (1996)
10.1210/JCEM.81.7.8675563
Regulation of the insulin-like growth factor system by insulin in burn patients.
C. Lang (1996)
10.1037/0278-6133.15.5.332
Fates worse than death: the role of valued life activities in health-state evaluations.
P. Ditto (1996)
10.1161/01.CIR.94.3.273
Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.
B. Lamarche (1996)
10.1001/ARCHINTE.156.19.2165
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association.
P. Singer (1996)
10.1016/S0026-0495(96)90207-3
Assessment of functional liver mass and plasma flow in acromegaly before and after long-term treatment with octreotide.
P. Avagnina (1996)
10.1007/s002689900129
Thyroid Cancer Detected by Ultrasound-Guided Fine-Needle Aspiration Biopsy
T. Yokozawa (1996)
10.1056/NEJM199610033351401
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
F. Sacks (1996)
10.1001/JAMA.1996.03540170041030
The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.
L. Speroff (1996)
10.1001/ARCHINTE.1996.00440180017002
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association.
P. Singer (1996)
Treatment guidelines for patients with thyroid nodules and welldifferentiated thyroid cancer
PA Singer (1996)
10.1001/JAMA.1997.03540440058033
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials.
P. Whelton (1997)
10.1046/j.1365-2265.1997.1680985.x
The thyroid gland in acromegaly: an ultrasonographic study
N. Cheung (1997)
10.2337/diab.46.5.814
Contribution of Autonomic Neuropathy to Reduced Plasma Adrenaline Responses to Hypoglycemia in IDDM: Evidence for a Nonselective Defect
P. Bottini (1997)
Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
M. Dottorini (1997)
10.1016/S0005-7916(97)00030-X
Treatment of menopausal symptoms with applied relaxation: a pilot study.
K. Wijma (1997)
10.1002/(SICI)1097-0142(19971201)80:11<2156::AID-CNCR16>3.0.CO;2-Y
Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology
J. Farahati (1997)
10.1210/JCEM.82.10.4249
Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.
A. Barkan (1997)
10.1016/S0039-6060(97)90226-9
Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas.
C. K. Brown (1997)
10.1210/JCEM.82.12.4428
Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation.
A. Schneider (1997)
10.1016/S0360-3016(97)00335-0
Radiotherapy for pituitary adenoma: long-term outcome and sequelae.
M. W. McCord (1997)
10.1210/endo.138.3.4979
Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β.
G. Kuiper (1997)
10.1016/S0378-5122(97)00041-8
The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.
E. Barrett-Connor (1997)
10.1210/JCEM.82.4.3864
Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas.
S. Chaidarun (1997)
10.1016/S0194-5998(97)70235-3
Nodular thyroid disease in children and adolescents.
B. Millman (1997)
10.3109/9781420070651-7
Differentiated thyroid carcinoma.
J. Hershman (1997)
10.2337/diab.46.8.1328
Effects of Differing Antecedent Hypoglycemia on Subsequent Counterregulation in Normal Humans
S. Davis (1997)
10.1515/JPEM.1997.10.6.561
Carcinoma of the Thyroid in Children - A Review
R. Feinmesser (1997)
Differentiated and medullary thyroid cancer in childhood and adolescence.
L. Mp (1997)
10.3171/JNS.1997.87.4.0499
Pathophysiology of hyponatremia after transsphenoidal pituitary surgery.
B. Olson (1997)
Differentiated and medullary thyroid cancer in childhood and adolescence.
M. La Quaglia (1997)
10.1016/S0022-3468(97)90618-7
Heterotopic autotransplantation of parathyroid tissue in children undergoing total thyroidectomy.
M. Skinner (1997)
10.1136/bmj.315.7116.1105
Why some cases of retinopathy worsen when diabetic control improves
E. Chantelau (1997)
10.7326/0003-4819-127-11-199712010-00004
The Role of Hormone Replacement Therapy in the Risk for Breast Cancer and Total Mortality in Women with a Family History of Breast Cancer
T. Sellers (1997)
10.1038/NG0597-64
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
D. Liaw (1997)
10.1016/S0378-5122(98)00004-8
Physical exercise and vasomotor symptoms in postmenopausal women.
T. Ivarsson (1998)
10.3171/JNS.1998.88.6.1002
Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy.
A. Landolt (1998)
10.1097/00006123-199805000-00036
Recent results of secondary transnasal surgery for residual or recurring acromegaly.
T. Abe (1998)
10.2337/DIACARE.21.11.1960
Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
C. Meyer (1998)
10.1056/NEJM199806043382303
Decreased epinephrine responses to hypoglycemia during sleep.
T. Jones (1998)
10.1016/S0002-9149(98)00010-1
Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group.
J. Fruchart (1998)
10.1016/S0140-6736(98)07037-8
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
R. Turner (1998)
10.1210/JCEM.83.8.5045
Multiple endocrine neoplasia--syndromes of the twentieth century.
R. Thakker (1998)
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
R. Turner (1998)
10.1007/s001250051065
Risk factors of severe hypoglycaemia in adult patients with Type I diabetes – a prospective population based study
I. Mühlhauser (1998)
10.1210/JCEM.83.8.5007
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study
S. Orme (1998)
10.1210/JCEM.83.6.4865
Reversibility of joint thickening in acromegalic patients: an ultrasonography study.
A. Colao (1998)
10.1001/JAMA.280.18.1569
Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.
D. Eisenberg (1998)
10.1210/JCEM.83.11.5266
Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
P. Freda (1998)
10.1089/THY.1998.8.737
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
D. Cooper (1998)
ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription
J. Roitman (1998)
10.1210/JCEM.83.3.4615
Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules.
E. Papini (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
R. Turner (1998)
10.7326/0003-4819-128-3-199802010-00001
United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy
A. Wright (1998)
10.1210/JCEM.83.2.4556
Cabergoline in the treatment of acromegaly: a study in 64 patients.
R. Abs (1998)
10.1210/JCEM.83.4.4683
Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
C. Spencer (1998)
10.1001/JAMA.279.19.1548
Why patients use alternative medicine: results of a national study.
J. Astin (1998)
10.1046/j.1365-2265.1998.00584.x
Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults
C. Welch Dinauer (1998)
10.1097/00000658-199804000-00014
Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group.
K. Newman (1998)
10.1210/JCEM.83.3.4635
Pregnancy in acromegaly: successful therapeutic outcome.
V. Herman-Bonert (1998)
10.3171/JNS.1998.89.3.0353
Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
P. Freda (1998)
10.1210/JCEM.83.10.5222
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.
B. Swearingen (1998)
10.7326/0003-4819-128-5-199803010-00008
Thyroxine Suppressive Therapy in Patients with Nodular Thyroid Disease
H. Gharib (1998)
10.1210/JCEM.83.7.4966
Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis.
C. Skjaerbaek (1998)
10.1007/978-3-540-35280-8_2484
[Thyroid tumors].
J. Luton (1998)
10.1056/NEJM199807233390404
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
S. Haffner (1998)
10.1001/JAMA.279.20.1615
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
J. Downs (1998)
Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
A. Samuel (1998)
10.1200/JCO.1998.16.2.495
Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.
D. Barton (1998)
10.1016/S0720-048X(97)00184-8
Preoperative staging of thyroid papillary carcinoma with ultrasonography.
K. Shimamoto (1998)
10.1002/(SICI)1097-0347(199809)20:6<549::AID-HED10>3.0.CO;2-R
Differentiated thyroid cancer in children and adolescents: Clinical outcome and mortality after long‐term follow‐up
R. Vassilopoulou-sellin (1998)
NEW APPROACHES TO THE DEVELOPMENT AND USE OF TREATMENT GUIDELINES
N. Johnson (1998)
Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clinical endocrinology 49:619628
CA Welch Dinauer (1998)
Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term followup
R Vassilopoulou-Sellin (1998)
10.1159/000023308
Suppression of Growth Hormone by Oral Glucose in the Evaluation of Tall Stature
R. Holl (1999)
10.1210/JCEM.84.5.5645
Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes.
F. J. Service (1999)
10.7326/0003-4819-130-5-199903020-00002
Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus
Hannele Yki-Jrvinen (1999)
10.1210/JCEM.84.8.5858
Menstrual irregularity in women with acromegaly.
G. Kaltsas (1999)
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
R. Marchioli (1999)
10.1016/S0002-9378(99)70437-0
Reduced thermoregulatory null zone in postmenopausal women with hot flashes.
R. Freedman (1999)
10.1210/JCEM.84.5.5674
Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study.
A. Colao (1999)
10.1677/ERC.0.0060449
Multiple endocrine neoplasia type 1.
A. A. Pannett (1999)
10.1016/S0002-9149(99)00135-6
Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog).
J. Hradec (1999)
10.1093/CARCIN/20.12.2247
Microsatellite instability and loss of heterozygosity in radiation-associated thyroid carcinomas of Belarussian children and adults.
H. Richter (1999)
10.1016/S0360-3016(99)00159-5
The incidence of cerebrovascular accidents in patients with pituitary adenoma.
M. Brada (1999)
10.1006/EXCR.1999.4661
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells.
S. Gray (1999)
10.1056/NEJM199908053410604
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.
H. Rubins (1999)
10.1056/NEJM199909023411004
Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix.
M. Seckl (1999)
10.1515/JPEM.1999.12.6.907
Pituitary Gigantism Causing Diabetic Ketoacidosis
N. Alvi (1999)
10.1097/00006123-199907000-00001
Growth hormone-secreting pituitary adenomas in childhood and adolescence: features and results of transnasal surgery.
T. Abe (1999)
10.3109/13697139909025557
Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women.
C. Nagata (1999)
10.1530/EJE.0.1400528
Clinical and morphological features of undifferentiated monomorphous GH/TSH-secreting pituitary adenoma.
T. Škorić (1999)
10.1016/S0029-7844(99)00266-5
Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss.
H. B. Leonetti (1999)
10.4065/74.7.661
Preliminary comparison of the endoscopic transnasal vs the sublabial transseptal approach for clinically nonfunctioning pituitary macroadenomas.
M. Sheehan (1999)
10.1016/S0140-6736(98)10233-7
Low-potency oestrogen and risk of endometrial cancer: a case-control study
E. Weiderpass (1999)
10.1016/S0261-5614(99)80076-4
Nutritional status, insulin-like growth factor-1 and quality of life in elderly women with hip fractures.
S. Ponzer (1999)
10.1210/JCEM.84.2.5467
Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients.
R. Baldelli (1999)
10.1046/J.1523-1755.1999.00798.X
Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
J. Frystyk (1999)
10.1007/s002340050839
MRI of growth hormone-secreting pituitary adenomas: factors determining pretreatment hormone levels
N. Saeki (1999)
10.1046/j.1464-5491.1999.00075.x
The British Diabetic Association Cohort Study, I: all‐cause mortality in patients with insulin‐treated diabetes mellitus
S. Laing (1999)
10.1093/AJCP/112.3.311
Post fine-needle aspiration histologic alterations of thyroid revisited.
Z. Baloch (1999)
10.1210/JCEM.84.3.5527
Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma.
S. Koong (1999)
Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid?
J. Farahati (1999)
10.1210/JCEM.85.2.6338
Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
P. Jaquet (2000)
10.1053/JPSU.2000.6935
Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
M. La Quaglia (2000)
10.1210/JCEM.85.11.6934
The prolonged fast.
F. J. Service (2000)
10.1210/JCEM.85.5.6586
Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure.
J. Powell (2000)
10.1016/S0161-6420(00)00060-9
Goldmann perimetry in acromegaly: a survey of 307 cases from 1951 through 1996.
O. Rivoal (2000)
10.1210/JCEM.85.3.6464
Octreotide may act as a radioprotective agent in acromegaly.
A. Landolt (2000)
10.1207/S15327914NC3601_5
Interindividual Variation in Metabolism of Soy Isoflavones and Lignans: Influence of Habitual Diet on Equol Production by the Gut Microflora
I. Rowland (2000)
10.1210/JCEM.85.7.6699
Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.
N. Biermasz (2000)
10.1038/sj.ejcn.1600935
Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24 h values
N. Knudsen (2000)
10.1046/J.1524-4733.2000.34003.X
The reliability and validity of the impact on lifestyle questionnaire in patients with acromegaly.
W. Lenderking (2000)
10.4158/EP.6.5.401
Management of thyroid cancer: radioiodine ablation, "stunning," and treatment of thyroglobulin-positive, (131)I scan-negative patients.
J. Hurley (2000)
10.1038/sj.onc.1203723
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway
H. Saavedra (2000)
10.3171/JNS.2000.93.1.0129
Transcranial-transdural real-time ultrasonography during transsphenoidal resection of a large pituitary tumor. Case report.
J. Atkinson (2000)
10.1067/MSY.2000.110243
Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients.
G. Thompson (2000)
10.1210/JCEM.85.1.6309
Pituitary tumor registry: a novel clinical resource.
M. R. Drange (2000)
10.1002/1096-911X(200007)35:1<41::AID-MPO7>3.0.CO;2-7
Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma.
A. Alessandri (2000)
10.1093/jnci/92.4.328
RESPONSE: re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin
Ross (2000)
10.1210/JCEM.85.10.6870
Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.
G. Barrande (2000)
10.1097/00042192-200007040-00005
Vasomotor Symptom Relief by Soy Isoflavone Extract Tablets in Postmenopausal Women: A Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Study
D. Upmalis (2000)
10.1056/NEJM200004203421604
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
P. E. J. T. Rainer (2000)
10.1093/AJE/152.5.463
Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age.
E. Gold (2000)
10.1046/j.1365-2265.2000.01095.x
Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels
N. Biermasz (2000)
10.1080/110241500750008718
Insular thyroid carcinoma in adolescents.
C. Lo (2000)
10.1210/JC.85.2.526
Criteria for cure of acromegaly: a consensus statement.
A. Giustina (2000)
Clinical and reimbursement issues in growth hormone use in adults.
B. Biller (2000)
10.1016/S1383-5718(00)00064-4
Equal induction and persistence of chromosome aberrations involving chromosomes 1, 4 and 10 in thyroid cancer patients treated with radioactive iodine.
S. Puerto (2000)
10.1210/JCEM.85.9.6808
Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study.
C. Sklar (2000)
10.7326/0003-4819-132-10-200005160-00004
Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study
K. Pandya (2000)
10.1016/S0959-8049(99)00281-6
Thyroid cancer in children: the Royal Marsden Hospital experience.
D. Landau (2000)
10.1200/JCO.2000.18.5.1068
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial.
S. Quella (2000)
10.1016/S0039-128X(00)00119-7
Nestorone®: a progestin with a unique pharmacological profile
N. Kumar (2000)
10.1067/MSY.2000.109728
Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis.
J. Brink (2000)
10.1210/JCEM.85.3.6472
The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults.
C. Fenton (2000)
10.1136/bmj.321.7258.412
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
A. Adler (2000)
10.1016/S0002-9149(00)00703-7
Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia.
A. Goldberg (2000)
10.1161/01.CIR.102.9.1014
Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry
Klas Malmberg (2000)
10.1093/OXFORDJOURNALS.BJA.A013400
Anaesthetic complications of acromegaly.
P. Seidman (2000)
10.1210/JCEM.85.9.6775
The prevalence and characteristics of colorectal neoplasia in acromegaly.
A. Renehan (2000)
10.1067/MSY.2000.110848
Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
O. Alsanea (2000)
10.1007/s002590000271
Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children
B. Jarzab (2000)
10.1016/S0140-6736(00)03403-6
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial
C. Loprinzi (2000)
10.7326/0003-4819-133-12-200012190-00008
A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease
F. Grodstein (2000)
10.1089/152460901750067133
Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women.
E. Freeman (2001)
10.4158/EP.7.3.170
Longitudinal assessment of economic burden and clinical outcomes in acromegaly.
L. Wilson (2001)
10.1016/S0140-6736(00)04006-X
Association between premature mortality and hypopituitarism
J. Tomlinson (2001)
10.1056/NEJMOA011090
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
B. G. Brown (2001)
10.1089/10507250152740975
Differentiated thyroid carcinoma: a polygenic disease.
T. Links (2001)
10.1097/00006231-200108000-00006
Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone
C. Bal (2001)
10.7326/0003-4819-135-12-200112180-00005
Effects of Diet and Sodium Intake on Blood Pressure: Subgroup Analysis of the DASH-Sodium Trial
W. Vollmer (2001)
10.1089/10507250152484628
Long-term follow-up of patients with initially benign thyroid fine-needle aspirations.
Y. Liel (2001)
10.1210/JCEM.86.12.8070
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
M. Brandi (2001)
10.1007/s00268-001-0198-x
Metastatic Differentiated Thyroid Carcinoma: ClinicopathologicalProfile and Outcome in an Iodine Deficient Area
Anjali Mishra (2001)
10.3171/JNS.2001.95.2.0285
Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma.
H. Ikeda (2001)
10.1590/S0100-879X2001001100009
Risk factors for glucose intolerance in active acromegaly.
A. Kréze (2001)
10.1001/ARCHSURG.136.6.656
Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma.
R. Witteles (2001)
10.1002/1097-0142(20010201)91:3<505::AID-CNCR1029>3.0.CO;2-6
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature
L. Thompson (2001)
10.1210/JCEM.86.7.7628
Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
P. Marzullo (2001)
10.1210/JCEM.86.4.7376
Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
A. Colao (2001)
10.2337/DIACARE.24.11.1878
Risk factors for frequent and severe hypoglycemia in type 1 diabetes.
C. Allen (2001)
10.1210/JCEM.86.7.7678
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
R. Elisei (2001)
10.1210/JCEM.86.9.7819
Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
J. Kreutzer (2001)
10.4158/EP.7.3.202
AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.
R. Cobin (2001)
10.1200/JCO.2001.19.10.2739
Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
J. Jacobson (2001)
10.1210/JCEM.86.7.7620
Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
D. Danila (2001)
10.1016/S0360-3016(01)01535-8
Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland.
S. Milker-Zabel (2001)
10.1089/10507250152741028
Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.
W. Wang (2001)
10.7326/0003-4819-135-1-200107030-00003
Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational Study
F. Grodstein (2001)
10.1001/JAMA.285.11.1489
Hormone replacement therapy and cognition: systematic review and meta-analysis.
E. LeBlanc (2001)
10.1530/EJE.0.1440109
Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly.
B. Gutt (2001)
10.1056/NEJMOA011300
Intensive insulin therapy in critically ill patients.
G. Van den Berghe (2001)
10.1016/S0029-7844(01)01453-3
Hormone Replacement Therapy and Breast Cancer: A Qualitative Review
Trudy L. Bush (2001)
10.1056/NEJM200101043440101
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet
F. Sacks (2001)
10.1097/00000658-200105000-00016
Randomized Prospective Evaluation of Frozen-Section Analysis for Follicular Neoplasms of the Thyroid
Robert Udelsman (2001)
10.1016/S0140-6736(01)06844-1
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
A. J. Lely (2001)
10.1530/EJE.0.1450137
Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre.
T. Abe (2001)
10.1001/JAMA.285.13.1711
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.
G. Schwartz (2001)
10.1080/00365510152567103
Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement?
S. Valdemarsson (2001)
10.1530/EJE.0.1450717
Failure of radiotherapy in acromegaly.
R. Cozzi (2001)
10.1210/JCEM.86.10.7950
Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches.
A. Corrias (2001)
10.1097/00019048-200106000-00021
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
S. Grundy (2001)
10.1177/194589240101500411
Endoscopic Transnasal Pituitary Surgery: Report on 180 Cases
Shawn S. Nasseri (2001)
Thyroid Carcinoma Task Force 2001 AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma
RH Cobin (2001)
10.1016/s1062-1458(02)00911-x
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary
S. Yusuf (2002)
10.1097/00042192-200201000-00011
Dietary supplement use among menopausal women attending a San Francisco health conference
I. W. Kam (2002)
10.3171/JNS.2002.97.2.0293
Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas.
P. Cappabianca (2002)
10.1056/NEJMSA012528
Understanding the treatment preferences of seriously ill patients.
T. Fried (2002)
10.1001/ARCHINTE.162.14.1568
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
S. Grundy (2002)
10.1210/JC.2002-020210
Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma.
R. Kloos (2002)
10.1507/ENDOCRJ.49.379
Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3.
I. Fukuda (2002)
10.1097/00005792-200203000-00001
Clinical Course of the Syndrome of Autoantibodies to the Insulin Receptor (Type B Insulin Resistance): A 28-Year Perspective
E. Arioglu (2002)
10.1136/PMJ.78.916.92
Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer
L. Vini (2002)
10.1515/JPEM.2002.15.6.823
Hot Nodules in Children and Adolescents in Western Poland from 1996 to 2000: Clinical Analysis of 31 Patients
M. Niedziela (2002)
10.1007/BF03343956
Differentiated thyroid cancer in children and adolescents
D. Giuffrida (2002)
10.1007/S11883-002-0059-6
Goals of statin therapy: Three viewpoints
G. Thompson (2002)
10.1053/JPSU.2002.36214
Pediatric surgical images: PET evaluation of papillary thyroid carcinoma recurrence.
S. Armstrong (2002)
10.1007/BF03345491
Effects of two different somatostatin analogs on glucose tolerance in acromegaly
C. Ronchi (2002)
10.1185/030079902125000787
Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention
V. Athyros (2002)
10.1001/JAMA.288.1.49
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
D. Grady (2002)
10.1080/00313020220131291
Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma
K. Mai (2002)
10.1001/JAMA.288.3.321
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
J. Rossouw (2002)
10.5694/j.1326-5377.2002.tb04886.x
Black cohosh and other herbal remedies associated with acute hepatitis
P. W. Whiting (2002)
10.1001/JAMA.288.23.2981
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
C. Furberg (2002)
10.1016/S0140-6736(02)11911-8
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
Sarah Lewington (2002)
10.1016/S1072-7515(02)01139-0
Well-differentiated thyroid carcinoma in Hong Kong Chinese patients under 21 years of age: a 35-year experience.
Y. Lee (2002)
10.1210/JCEM.87.8.8811
Acromegaly—Consensus, What Consensus?
P. Trainer (2002)
10.1002/JSO.10115
Diagnosis and management of patients with thyroid nodules
W. Lawrence (2002)
10.1007/BF03345496
Gender- and age-related differences in the endocrine parameters of acromegaly
A. Colao (2002)
10.1203/00006450-200211000-00021
Differentiated Thyroid Carcinoma That Express Sodium-Iodide Symporter Have a Lower Risk of Recurrence for Children and Adolescents
Aneeta Patel (2002)
10.3171/JNS.2002.96.2.0195
The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
B. Meij (2002)
10.1056/NEJMOA012512
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
W. Knowler (2002)
10.1093/JN/132.12.3577
The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.
K. Setchell (2002)
10.1089/105072502760258668
Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review.
W. Hung (2002)
10.1002/dmrr.271
Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences
E. T. ter Braak (2002)
10.1001/ARCHINTE.162.20.2269
Prevalence, expenditures, and complications of multiple chronic conditions in the elderly.
J. Wolff (2002)
10.1002/cncr.10725
Childhood and adolescent thyroid carcinoma
P. Grigsby (2002)
10.1210/JCEM.87.7.8702
Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?
R. Robbins (2002)
10.1016/S0140-6736(02)11600-X
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J. Shepherd (2002)
10.1677/ERC.0.0090227
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.
E. Mazzaferri (2002)
10.1136/bmj.324.7343.939
Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
J. Evans (2002)
10.2337/DIACARE.25.3.554
Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy.
I. Evers (2002)
10.1200/JCO.2002.20.6.1449
Effect of Soy Phytoestrogens on Hot Flashes in Postmenopausal Women With Breast Cancer: A Randomized, Controlled Clinical Trial
C. Patten (2002)
10.7326/0003-4819-137-2-200207160-00009
Unexpected Hypoglycemia in a Critically Ill Patient
D. Bates (2002)
10.1210/JCEM.87.8.8658
Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.
E. Dimaraki (2002)
10.1016/S0002-9149(02)02418-9
Genomic and nongenomic effects of estrogen in the vasculature.
M. Mendelsohn (2002)
10.1210/JC.2002-020365
Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
J. Wemeau (2002)
10.1046/j.1365-2265.2002.t01-1-01545.x
Testicular dose and fertility in men following I131 therapy for thyroid cancer
S. Hyer (2002)
10.1046/J.1365-2265.2002.01574.X
Does radioiodine therapy have disadvantageous effects in non‐iodine accumulating differentiated thyroid carcinoma?
J. Schaap (2002)
10.1093/ANNONC/MDF151
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study.
G. Bertelli (2002)
10.1001/JAMA.287.24.3215
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.
P. Serruys (2002)
10.2337/DIABETES.51.3.724
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
S. A. Segel (2002)
10.1159/000057960
Insulin-Like Growth Factors and Insulin-Like Growth Factor Binding Proteins in Adult Patients with Severe Liver Disease before and after Orthotopic Liver Transplantation
M. Weber (2002)
10.1046/j.1365-2265.2002.01592.x
Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation
J. Chung (2002)
10.1007/s00125-002-0822-9
Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes*
P. Cryer (2002)
10.1210/JCEM.87.4.8274
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment.
F. Pacini (2002)
10.1093/AJCN/76.1.239
Serum concentrations of sex hormone binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus.
Nathalie Pascal (2002)
Hot nodules in children and adolescents in western Poland 750 FRANCIS ET AL. from 1996 to 2000: clinical analysis of 31 patients
M Niedziela (2002)
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have Page 67 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 80
F Pacini (2002)
Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area. World journal of surgery 26:153-157
A Mishra (2002)
Does radioiodine therapy have disadvantageous effects in noniodine accumulating differentiated thyroid carcinoma? Clinical endocrinology 57:117124
J Schaap (2002)
Current controversies in the management of pediatric patients with well - differentiated non - medullary
W Hung (2002)
10.1159/000071871
Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study
G. Brabant (2003)
10.1515/JPEM.2003.16.7.1033
Treatment of Recurrent Papillary Thyroid Carcinoma in Children and Adolescents
P. Powers (2003)
10.1210/JC.2002-021642
Thyroid Carcinoma in the McCune-Albright Syndrome: Contributory Role of Activating Gsα Mutations
M. Collins (2003)
10.1210/JC.2002-021516
Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition.
C. Welt (2003)
10.2337/DIACARE.26.4.1176
Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.
G. Leese (2003)
10.7326/0003-4819-139-5_Part_1-200309020-00010
Disappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens
L. Chiovato (2003)
10.2337/DIACARE.26.3.832
Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.
M. Steffes (2003)
10.1089/105072503322021142
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer.
A. Antonelli (2003)
10.1080/cmt.6.4.302.313
Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial
S. Shapiro (2003)
Greater local recurrence occurs with "berry picking" than neck dissection in thyroid cancer.
Michael J. Musacchio (2003)
10.1007/BF02724312
Differentiated thyroid cancer
Ajay Kumar (2003)
10.1038/sj.bjc.6601319
Second primary malignancies in thyroid cancer patients
C. Rubino (2003)
10.1016/S0002-8703(03)00367-3
Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
M. Yokoyama (2003)
10.1093/JNCI/95.1.30
Postmenopausal hormone therapy and change in mammographic density.
G. Greendale (2003)
10.2337/diacare.26.6.1902
Hypoglycemia in diabetes.
P. Cryer (2003)
10.1530/EJE.0.1480281
Non-genomic actions of sex steroid hormones.
T. Simoncini (2003)
10.1001/JAMA.290.8.1042
Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
K. Prestwood (2003)
10.1210/JC.2002-021663
Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study.
R. Attanasio (2003)
10.1016/S0140-6736(03)14283-3
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
J. McMurray (2003)
10.1136/adc.88.11.956
Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients
I. Sermet‐Gaudelus (2003)
10.1002/cncr.11205
Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden
H. Olsson (2003)
10.1055/S-2003-42728
Clinical characterisation of severe hypoglycaemia--a prospective population-based study.
A. Holstein (2003)
10.1530/EJE.0.1490521
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant.
W. Drake (2003)
10.1210/JC.2003-030461
Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume.
F. Barker (2003)
10.1001/JAMA.289.21.2827
Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
V. Stearns (2003)
10.1097/00008480-200310000-00010
Insular carcinoma of the thyroid in an adolescent: a case report and review of the literature.
K. Yusuf (2003)
10.1001/ARCHOTOL.129.7.746
Long-term survival rates in young patients with thyroid carcinoma.
L. Kowalski (2003)
10.1001/JAMA.289.17.2254
Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
D. Dewitt (2003)
10.2337/DIABETES.52.5.1195
Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia.
S. Banarer (2003)
10.1530/EJE.0.1480031
Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly.
A. Colao (2003)
10.1210/JC.2002-021925
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma.
F. Pacini (2003)
10.1001/JAMA.289.24.3243
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial
R. Chlebowski (2003)
10.1016/S0039-128X(03)00123-5
MPA and postmenopausal coronary artery atherosclerosis revisited
T. Clarkson (2003)
10.1001/JAMA.289.24.3254
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Christopher I. Li (2003)
10.2337/DIACARE.26.2.349
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).
M. Henricsson (2003)
10.1046/j.1464-5491.2003.01072.x
Hypoglycaemia in insulin‐treated Type 2 diabetes: frequency, symptoms and impaired awareness
J. Henderson (2003)
10.2337/DIABETES.52.6.1469
Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia.
R. Robinson (2003)
10.1046/j.1365-2265.2003.01735.x
Effects of low‐iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma
Maurice J H M Pluijmen (2003)
10.1016/S0140-6736(03)12663-3
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
A. Sniderman (2003)
10.1210/JC.2002-021365
Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients.
E. Baudin (2003)
10.1016/S1096-6374(03)00038-8
Serum levels of insulin-like growth factor I and its binding proteins in health and disease.
A. Juul (2003)
10.1210/JC.2002-021099
High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study.
A. Colao (2003)
10.1210/JC.2002-021702
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
E. Mazzaferri (2003)
10.1016/S0378-5122(03)00087-2
Menopause after breast cancer: a survey on breast cancer survivors.
N. Biglia (2003)
10.1046/j.1365-2265.2003.01689.x
Reversal of acromegalic cardiomyopathy in young but not in middle‐aged patients after 12 months of treatment with the depot long‐acting somatostatin analogue octreotide
A. Colao (2003)
10.1016/S1096-6374(03)00054-6
Pituitary tumors and pregnancy.
M. Molitch (2003)
10.1002/cncr.11031
Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma
A. Frasoldati (2003)
10.1210/JC.2003-030518
Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm.
D. Clemmons (2003)
10.1515/JPEM.2003.16.5.693
Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and Adolescents
P. Powers (2003)
10.3171/JNS.2003.98.4.0719
Assessment of long-term remission of acromegaly following surgery.
M. Krieger (2003)
10.1007/s00259-003-1174-5
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
E. Hindié (2003)
10.4158/EP.9.6.544
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.
S. Hodgson (2003)
10.1016/S1054-139X(03)00057-0
Cancer incidence in adolescents and young adults in the United States, 1992-1997.
Xiao-Cheng Wu (2003)
10.1046/j.1365-2362.2003.01158.x
Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism
K. Kaczirek (2003)
10.2337/DIACARE.26.11.3080
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
M. Riddle (2003)
10.1046/j.1464-5491.2003.01033.x
An unusual cause of hyperinsulinaemic hypoglycaemia syndrome
P. Manning (2003)
10.1001/JAMA.289.19.2560
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
A. Chobanian (2003)
10.1016/S0039-6060(03)00424-0
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer.
M. Kouvaraki (2003)
10.1097/00042192-200310010-00004
Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women.
B. Wren (2003)
10.1007/BF03345139
Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly
S. Grottoli (2003)
10.1016/S0378-5122(02)00350-X
The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
W. Wuttke (2003)
10.1007/s00261-003-0162-3
Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS
B. Kumbasar (2003)
GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER 745 D ow nl oa de d by
C Rubino (2003)
Recombinant human thyrotropinstimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma
F Pacini (2003)
Longterm survival rates in young patients with thyroid carcinoma. Archives of otolaryngology--head & neck surgery 129:746-749
LP Kowalski (2003)
GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER
C Rubino (2003)
ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER
C Rubino (2003)
10.1530/EJE.0.1510309
Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly.
B. Herrmann (2004)
Endoscopic ultrasound and neuroendocrine tumours of the pancreas.
A. Fritscher-ravens (2004)
10.1001/ARCHNEUR.61.5.721
Pituitary volume and headache: size is not everything.
M. Levy (2004)
10.1016/J.IJROBP.2003.12.012
Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma.
S. Milker-Zabel (2004)
10.1530/EJE.0.1500763
Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
A. Bourdelot (2004)
10.1023/A:1020750514954
Cardiovascular Complications in Acromegaly: Methods of Assessment
G. Vitale (2004)
10.1210/JC.2003-031584
Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.
J. Ayuk (2004)
10.3171/JNS.2004.100.2.0278
Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions.
S. Wolfsberger (2004)
10.2337/DIABETES.53.6.1592
A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene.
K. Højlund (2004)
10.1007/BF00169997
Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations
D. Casara (2004)
10.1001/JAMA.292.11.1307
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
J. D. de Lemos (2004)
10.1161/01.CIR.0000133317.49796.0E
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
S. Grundy (2004)
10.1007/BF00399957
Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus
G. Massa (2004)
10.1002/PBC.10410
Differentiated thyroid carcinoma in childhood and adolescence—clinical course and role of radioiodine
S. Chow (2004)
10.1210/JC.2004-0669
Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess.
N. Biermasz (2004)
10.1097/01.GME.0000094356.92081.EF
Bioidentical hormone therapy: a review
L. Boothby (2004)
10.1515/JPEM.2004.17.3.339
The MACIS Score Predicts the Clinical Course of Papillary Thyroid Carcinoma in Children and Adolescents
P. Powers (2004)
Papillary thyroid cancer with chest metastases only detected using radioactive iodine.
Sheng-Fong Kuo (2004)
Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue.
A. Faggiano (2004)
10.1023/A:1012969719503
Endoscopic transsphenoidal surgery
H. Jho (2004)
10.1097/00006231-200402000-00006
Clinical implications of the differences between diagnostic 123I and post-therapy 131I scans
Jason B Cohen (2004)
10.3171/JNS.2004.100.3.0557
Intrasellar aneurysm and a growth hormone-secreting pituitary macroadenoma. Case report.
B. Sade (2004)
10.1056/NEJMOA040583
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
C. Cannon (2004)
10.2337/DIABETES.53.6.1535
Influence of autonomic neuropathy on QTc interval lengthening during hypoglycemia in type 1 diabetes.
Stuart Lee (2004)
10.1111/j.1365-2265.2004.02138.x
Radiosurgery for pituitary adenomas
M. Brada (2004)
10.1016/J.EJCA.2004.02.009
Follicular-cell derived thyroid cancer in children.
S. Leboulleux (2004)
10.1161/01.CIR.0000115514.44135.A8
Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report From the Women’s Ischemia Syndrome Evaluation (WISE) Study
K. Kip (2004)
10.1210/JC.2003-031289
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrine.
B. D. de Galan (2004)
10.1016/J.YPMED.2003.11.027
A meta-analysis of alcohol consumption and the risk of 15 diseases.
G. Corrao (2004)
10.1210/JC.2003-032141
Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery.
E. Zirkzee (2004)
10.1001/ARCHINTE.164.13.1438
Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.
O. Vaccaro (2004)
10.1023/A:1022145116901
Self Image and Quality of Life in Acromegaly
P. Pantanetti (2004)
Surgeon-performed ultrasound in the management of thyroid malignancy.
C. Solórzano (2004)
10.1016/J.JACC.2004.07.053
Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
M. Koren (2004)
10.1023/A:1009904031687
Confusion in Clinical Laboratory GH and IGF-I Reprots
S. Melmed (2004)
10.1210/JC.2002-020480
Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.
S. Kemp (2004)
10.1023/A:1008974215622
Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA)
M. Slattery (2004)
10.1016/S0140-6736(04)16895-5
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
H. Colhoun (2004)
10.1016/S0940-9602(04)80013-X
A meta-analysis of superior thyroid artery variations in different human groups and their clinical implications.
R. Toni (2004)
10.1210/ER.2002-0022
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
A. Colao (2004)
10.1023/A:1012949214960
Acromegaly: historical perspectives and current therapy
J. Jane (2004)
10.1016/S0195-668X(03)00468-8
Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.
M. Hanefeld (2004)
10.2337/DIACARE.27.1.201
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
R. Stevens (2004)
10.1002/PBC.10421
A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster
M. Niedziela (2004)
10.1111/j.1365-2265.2004.02060.x
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
C. Eustatia-Rutten (2004)
10.1530/EJE.0.1500105
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective.
M. Schlumberger (2004)
10.1093/HUMREP/DEH112
Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial.
C. Antoine (2004)
10.1089/105072504773297894
Is chest x-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer?
C. Bal (2004)
10.1210/ER.2003-0014
The diagnosis and medical management of advanced neuroendocrine tumors.
G. Kaltsas (2004)
10.1001/JAMA.291.14.1701
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
G. Anderson (2004)
10.1016/J.ATHEROSCLEROSISSUP.2004.08.027
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.
T. Pedersen (2004)
10.1007/s00268-004-7605-z
Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma
G. Thompson (2004)
Pathology and genetics of tumours of endocrine organs
R. DeLellis (2004)
10.1530/EJE.0.1510439
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).
A. Mestrón (2004)
10.1089/THY.2004.14.959
Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes.
H. Baskin (2004)
10.1001/JAMA.292.1.65
Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial.
S. Kreijkamp-Kaspers (2004)
10.1097/01.RVI.0000140638.55375.1E
Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations.
P. Wiesli (2004)
10.1007/s00268-004-7630-y
Predictive Factors for Recurrence from a Series of 74 Children and Adolescents with Differentiated Thyroid Cancer
F. Borson-Chazot (2004)
10.1007/BF00399801
Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM
C. Fanelli (2004)
10.1210/JC.2003-031573
Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.
R. Robbins (2004)
10.1530/EJE.0.1500481
Raloxifene decreases serum IGF-I in male patients with active acromegaly.
E. Dimaraki (2004)
10.1001/JAMA.291.13.1610
Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
H. Nelson (2004)
10.1097/01.GME.0000094209.15096.2B
Influence of marketed herbal menopause preparations on MCF-7 cell proliferation
C. Bodinet (2004)
10.1002/dmrr.482
Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection
U. Pedersen-Bjergaard (2004)
10.1093/ILAR.45.2.139
Hormone replacement therapy and cardiovascular disease: lessons from a monkey model of postmenopausal women.
J. Williams (2004)
10.1007/s00125-004-1552-y
Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes
N. Murphy (2004)
10.1136/bmj.328.7454.1490
Grading quality of evidence and strength of recommendations
D. Atkins (2004)
10.1097/01.GME.0000113932.56832.27
Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women
E. Aiello (2004)
10.1007/BF00052671
Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States
D. B. Willis (2004)
10.1002/cncr.20081
Follicular thyroid carcinoma: Histology and prognosis
A. D'avanzo (2004)
10.1016/J.JAMCOLLSURG.2003.11.012
Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
J. Furlan (2004)
10.1016/J.JACC.2004.03.046
Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal.
J. O’Keefe (2004)
10.1515/CCLM.2004.254
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk
G. Walldius (2004)
10.1007/s00259-004-1460-x
Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma
S. Ilgan (2004)
Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine. Pediatric blood & cancer
SM Chow (2004)
D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 18 9
A Faggiano (2004)
Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clinical endocrinology 61:61-74
CF Eustatia-Rutten (2004)
Is chest x-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer? Thyroid 14:217–225
CS Bal (2004)
Age-dependent 746 FRANCIS ET AL. variation of follicular size and expression of iodine transporters in human thyroid tissue
A Faggiano (2004)
10.1210/JC.2004-2090
A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
F. Miraki-Moud (2005)
10.1056/NEJMOA043690
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Geoffrey J Service (2005)
10.1097/01.pas.0000151617.14598.ae
Persistent Hyperinsulinemic Hypoglycemia in 15 Adults With Diffuse Nesidioblastosis: Diagnostic Criteria, Incidence, and Characterization of β-Cell Changes
M. Anlauf (2005)
10.1530/EJE.1.01824
Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.
P. Petrossians (2005)
10.1677/ERC.1.00880
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
B. Jarzab (2005)
10.1001/JAMA.294.19.2437
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
T. Pedersen (2005)
10.1056/NEJMOA050461
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
J. Larosa (2005)
Psychosocial aspects of survivors of childhood cancer or leukemia.
L. Massimo (2005)
10.1016/S0140-6736(05)67528-9
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
J. Dormandy (2005)
10.1007/BF01420508
Carpal tunnel syndrome and acromegaly
H. Baum (2005)
10.1016/S0140-6736(05)67663-5
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
S. Yusuf (2005)
10.1002/ajmg.c.30064
Risk of tumorigenesis in overgrowth syndromes: A comprehensive review
P. Lapunzina (2005)
10.1002/ijc.20710
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohort
A. Fournier (2005)
10.1210/JC.2005-0492
A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.
R. Kloos (2005)
10.1002/cncr.21055
The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma
A. Machens (2005)
10.1159/000084717
Follicular Cell-Derived Thyroid Cancer in Children
S. Leboulleux (2005)
10.1016/j.otohns.2005.06.007
Efficacy of Thyroid Hormone Suppression for Benign Thyroid Nodules: Meta-Analysis of Randomized Trials
M. Sdano (2005)
10.1111/j.1464-5491.2005.01501.x
Frequency and predictors of hypoglycaemia in Type 1 and insulin‐treated Type 2 diabetes: a population‐based study
L. Donnelly (2005)
10.1210/JC.2005-0998
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly.
S. Bhayana (2005)
10.1158/0008-5472.CAN-04-3314
Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
N. Mitsutake (2005)
10.1210/JC.2004-2009
Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly.
J. Puder (2005)
10.1530/EJE.1.02036
Consensus statement: medical management of acromegaly.
S. Melmed (2005)
10.1055/S-2005-870583
Massive insulin secretion in response to anaerobic exercise in exercise-induced hyperinsulinism.
T. Meissner (2005)
10.4158/EP.11.2.97
Insulin autoimmunity and hypoglycemia in seven white patients.
A. Basu (2005)
10.1056/NEJMOA052187
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
D. Nathan (2005)
10.2337/DIABETES.54.3.757
Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans.
B. Raju (2005)
10.1016/J.AMJCARD.2004.09.013
Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project).
P. Canner (2005)
10.1007/S11892-005-0055-7
Early nephropathy in type 1 diabetes: A new perspective on who will and who will not progress
B. Perkins (2005)
10.2337/DIACARE.28.4.950
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
J. Rosenstock (2005)
10.2337/DIACARE.28.7.1588
Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey.
Lucinda Whiteley (2005)
The acromegalic arthropathy.
A. Colao (2005)
10.1177/0272989X05280558
Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making
M. Man-Son-Hing (2005)
10.1056/NEJMOA043545
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
C. Wanner (2005)
10.1378/CHEST.128.3.1882
Cerebrospinal fluid leak and meningitis associated with nasal continuous positive airway pressure therapy.
T. Kuźniar (2005)
10.1002/DC.20197
Thyroid fine‐needle aspiration biopsy in children and adolescents: Experience with 218 aspirates
M. Amrikachi (2005)
10.1097/01.ruq.0000174750.27010.68
Sonography of Thyroid Nodules: A “Classic Pattern” Diagnostic Approach
C. Reading (2005)
10.1530/EJE.1.01940
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.
R. Görges (2005)
Androgens and body composition in the aging male.
M. Doga (2005)
10.2337/DIACARE.28.12.2823
Beneficial Effects of a Dietary Approaches to Stop Hypertension Eating Plan on Features of the Metabolic Syndrome
L. Azadbakht (2005)
10.1210/JC.2005-0311
Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion.
F. Castinetti (2005)
10.1097/01.sla.0000186421.30982.d2
Follicular Thyroid Carcinoma: The Role of Histology and Staging Systems in Predicting Survival
C. Lo (2005)
10.1016/J.BEEM.2004.11.002
Commentary: imaging of islet-cell tumours.
A. Grossman (2005)
10.1542/peds.2004-2331
Factitious Hyperinsulinism Leading to Pancreatectomy: Severe Forms of Munchausen Syndrome by Proxy
I. Giurgea (2005)
10.1210/JC.2004-1093
Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly.
J. Bevan (2005)
10.1007/BF02067317
Differentiated thyroid carcinoma in children and adolescents
J. Harness (2005)
10.1210/JC.2005-1550
Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer.
S. Iorcansky (2005)
10.1007/s00125-005-0127-x
Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients
L. Koppes (2005)
10.1093/GERONA/60.4.491
Predicting death in the nursing home: development and validation of the 6-month Minimum Data Set mortality risk index.
D. Porock (2005)
10.2337/DIABETES.54.4.1150
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
W. Knowler (2005)
10.1038/ncpendmet0020
Thyroid-hormone therapy and thyroid cancer: a reassessment
B. Biondi (2005)
10.1007/s11102-005-5351-3
Cerebrospinal Fluid Leakage During Transsphenoidal Surgery: Postoperative External Lumbar Drainage Reduces the Risk for Meningitis
M. O. van Aken (2005)
10.1007/s00125-005-1905-1
Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study
A. Sämann (2005)
10.1093/HUMREP/DEI043
Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review.
M. Dietel (2005)
10.1089/THY.2005.15.274
Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up.
A. Orlandi (2005)
10.1007/s00125-005-1933-x
Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia
M. Patti (2005)
10.1016/J.JPEDSURG.2005.07.029
The role of a more extensive surgical approach in the initial multimodality management of papillary thyroid cancer in children.
R. Savio (2005)
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
K. Nakada (2005)
10.2337/DIABETES.54.12.3592
Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes.
P. Cryer (2005)
10.1016/J.JACC.2005.02.080
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
P. Ridker (2005)
10.1016/J.AANAT.2005.04.004
A meta-analysis of inferior thyroid artery variations in different human ethnic groups and their clinical implications.
R. Toni (2005)
10.1210/JC.2004-0240
Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy.
M. Terzolo (2005)
10.1210/JC.2005-1085
Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal.
W. Kuijt (2005)
10.1016/J.JDIACOMP.2004.02.001
Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes.
G. Murata (2005)
10.1210/JC.2005-0260
Long-acting somatostatin analog therapy of acromegaly: a meta-analysis.
P. Freda (2005)
10.2337/DIACARE.28.5.1245
Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.
Workgroup on Hypoglycemia (2005)
10.1210/JC.2004-1381
A nationwide survey of mortality in acromegaly.
R. Kauppinen-Mäkelin (2005)
Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD.
J. Hippisley-Cox (2005)
10.1023/B:NEON.0000041887.51906.b7
Stereotactic Radiosurgery for Pituitary Adenomas: A Review of the Literature
E. Laws (2005)
10.1016/S0140-6736(05)63011-5
Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly
J. Feenstra (2005)
10.1007/s00268-005-0543-6
Islet Hyperplasia in Adults: Challenge to Preoperatively Diagnose Non-Insulinoma Pancreatogenic Hypoglycemia Syndrome
A. Starke (2005)
10.1089/THY.2005.15.320
BRAF mutations are uncommon in papillary thyroid cancer of young patients.
Karen Penko (2005)
10.1007/s10557-005-5686-z
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study
E. Bruckert (2005)
10.1016/J.BEEM.2004.11.012
Endoscopic ultrasound in the localisation of pancreatic islet cell tumours.
A. McLean (2005)
10.1016/S0140-6736(05)67667-2
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
A. Keech (2005)
10.1097/01.RUQ.0000226877.19937.A1
Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.
M. Frates (2005)
10.1530/EJE.1.01956
Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.
M. Rix (2005)
10.1210/JC.2004-2466
A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly.
S. Melmed (2005)
10.1210/JC.2004-0875
Clinically silent somatotropinomas may be biochemically active.
Alla A Sakharova (2005)
10.1148/RADIOL.2352031942
Diagnosis of thyroid cancer in children: value of gray-scale and power doppler US.
A. Lyshchik (2005)
10.1210/JC.2004-1152
Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.
G. Minniti (2005)
10.1007/s11102-005-5353-1
Cabergoline Decreases Somatotroph Adenoma Size: A Case Report
M. Rickels (2005)
10.1159/000095530
Acromegaly and the Cardiovascular System
G. Lombardi (2006)
10.2337/dc05-2465
Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes
J. Shepherd (2006)
10.1089/JWH.2006.15.35
Hormone Therapy and Coronary Heart Disease: The Role of Time since Menopause and Age at Hormone Initiation
F. Grodstein (2006)
10.1056/NEJMOA066224
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
S. Kahn (2006)
10.2337/DC06-0392
Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover.
J. Meier (2006)
10.1002/JSO.20700
Pathology and genetics of thyroid carcinoma
R. DeLellis (2006)
10.1136/bmj.38793.468449.AE
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: metaanalysis of randomised controlled trials
J. Costa (2006)
10.1677/ERC.1.00882
Pathogenesis, diagnosis and management of thyroid nodules in children.
M. Niedziela (2006)
10.1373/CLINCHEM.2005.060236
Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls.
H. Markkanen (2006)
10.1210/JC.2005-1705
The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
F. Boi (2006)
10.1007/BF02303556
Iodine 131 thyroid ablation in female children and adolescents: Long-term risk of infertility and birth defects
M. Smith (2006)
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
H. Hänscheid (2006)
10.1016/J.JACC.2006.04.070
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.
C. Cannon (2006)
10.1210/JC.2005-1534
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
R. Robbins (2006)
10.1111/j.1464-5491.2006.01880.x
Frequency and risk factors of severe hypoglycaemia in insulin‐treated Type 2 diabetes: a cross‐sectional survey
K. Akram (2006)
10.1530/EJE.1.02163
GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion.
A. A. van der Klaauw (2006)
10.1210/JC.2005-1185
Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy.
M. Torlontano (2006)
10.1056/NEJMOA052521
Intensive insulin therapy in the medical ICU.
G. Van den Berghe (2006)
10.1097/01.gme.0000196811.88505.10
Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study
M. Boccardi (2006)
10.1016/J.AMJCARD.2006.07.036
Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl.
W. Cromwell (2006)
10.1227/01.NEU.0000219198.38423.1E
Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas.
C. Nimsky (2006)
10.1016/j.otohns.2006.04.004
Thyroid Cancer in Children: Management and Outcome Experience of a Referral Center
A. Popovtzer (2006)
10.1667/RR3605.1
Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose Response and its Modifiers
C. Ronckers (2006)
10.2337/DIACARE.29.01.06.DC05-1686
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.
S. Garg (2006)
10.1111/j.1525-1497.2006.00389.x
Brief report: Coronary heart disease events associated with hormone therapy in younger and older women
S. Salpeter (2006)
10.3171/JNS.2006.104.6.899
Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates.
M. Losa (2006)
10.1007/s00268-006-0847-1
An Evidence-based Approach to Familial Nonmedullary Thyroid Cancer: Screening, Clinical Management, and Follow-up
R. Sippel (2006)
10.1001/ARCHINTE.166.6.605
Reconsidering medication appropriateness for patients late in life.
H. Holmes (2006)
10.1111/j.1365-2265.2006.02430.x
Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status
A. Espinosa-de-los-Monteros (2006)
10.1210/JC.2006-1668
High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
A. Daly (2006)
10.1055/S-2006-923887
Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes.
D. Deiss (2006)
10.1016/J.AMJCARD.2005.11.031
Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese.
T. Sakamoto (2006)
10.1016/J.JDIACOMP.2005.08.010
Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
A. Wright (2006)
10.1210/JC.2005-2798
Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments.
B. Raju (2006)
10.3322/canjclin.56.1.11
American Cancer Society Guidelines for the Early Detection of Cancer, 2006
R. Smith (2006)
10.1007/s00259-006-0341-x
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement
M. Urhan (2006)
10.1056/NEJMOA061894
High-dose atorvastatin after stroke or transient ischemic attack.
P. Amarenco (2006)
10.1210/ER.2004-0022
The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.
L. Woodhouse (2006)
10.1093/EURHEARTJ/EHL220
Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial.
S. Ahmed (2006)
10.1530/EJE.1.02186
Consensus statement on the standardisation of GH assays.
P. Trainer (2006)
10.1002/pbc.20541
Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma
M. Metzger (2006)
10.1097/01.med.0000244222.91280.71
Hyperinsulinemic hypoglycemia following gastric bypass surgery for obesity
A. Goldfine (2006)
10.1089/THY.2006.16.181
On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds.
N. D. Charkes (2006)
10.1097/01.sla.0000205977.74806.0b
Comprehensive Clinical Assessment of 740 Cases of Surgically Treated Thyroid Cancer in Children of Belarus
Y. Demidchik (2006)
10.1089/THY.2006.16.667
Testicular function after radioiodine therapy in patients with thyroid cancer.
P. Rosário (2006)
10.1530/EJE.1.02158
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
F. Pacini (2006)
10.1001/ARCHSURG.141.5.489
Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.
J. Stulak (2006)
10.1002/14651858.CD004641.PUB2
Potassium supplementation for the management of primary hypertension in adults.
H. Dickinson (2006)
10.1111/j.1365-2265.2006.02629.x
Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS)
J. G. Won (2006)
10.4158/EP.12.1.63
American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.
H. Gharib (2006)
10.1056/NEJMRA050776
Estrogen carcinogenesis in breast cancer.
J. Yager (2006)
10.1016/S0140-6736(06)69472-5
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
H. Nakamura (2006)
10.4158/EP.12.2.223
Endocrine University: evolution of a novel educational program.
H. Gharib (2006)
10.1515/JPEM.2006.19.12.1377
Evidence-based Review of Treatment and Follow up of Pediatric Patients with Differentiated Thyroid Carcinoma
M. Rachmiel (2006)
10.1111/j.1445-5994.2006.01149.x
Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy
W. Lau (2006)
10.1111/j.1365-2796.2006.01616.x
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel
P. Barter (2006)
10.1016/J.AHJ.2005.09.015
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
C. Stettler (2006)
10.1172/JCI28735
Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes.
P. Cryer (2006)
10.1530/EJE.1.02215
Pregnancy in acromegaly: a one-center experience.
R. Cozzi (2006)
10.1210/JC.2005-2110
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients.
A. Colao (2006)
10.1111/j.1464-5491.2005.01672.x
Continuous glucose monitoring and closed‐loop systems
R. Hovorka (2006)
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
R. M. Tuttle (2006)
10.1016/J.SURG.2006.08.001
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.
M. Sywak (2006)
10.1016/S1262-3636(07)70257-4
Meglitinide analogues: a review of clinical data focused on recent trials.
J. Blicklé (2006)
10.1016/J.PHYMED.2004.09.002
Muscle damage induced by black cohosh (Cimicifuga racemosa).
P. Minciullo (2006)
10.1210/JC.2006-1430
Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia.
P. Kar (2006)
Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule.
G. Sgouros (2006)
10.2337/db06-0419
Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes
G. Steil (2006)
10.1016/J.JACC.2006.04.026
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
S. Smith (2006)
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER
M Sywak (2006)
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER 751 D ow nl oa de d by
M Sywak (2006)
Pathogenesis, diagnosis and management of thyroid nodules in children. Endocrine-related cancer
M Niedziela (2006)
10.1210/JC.2006-1479
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
S. Kauhanen (2007)
10.14310/HORM.2002.1111023
Thyroid cancer in childhood: management strategy, including dosimetry and long-term results.
M. Luster (2007)
10.1097/MED.0b013e32825a675e
Real-time continuous glucose monitoring
B. Buckingham (2007)
10.1007/s11102-007-0078-y
Radiotherapy and radiosurgery in acromegaly
F. Castinetti (2007)
10.2337/dc07-0048
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
X. Pi-Sunyer (2007)
10.1007/s00125-007-0820-z
Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes
E. Kilpatrick (2007)
10.1097/MOL.0b013e3282364add
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety
J. Guyton (2007)
10.2967/jnumed.106.035535
Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid Cancer
D. Handkiewicz-Junak (2007)
10.1016/S0140-6736(07)60527-3
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
M. Yokoyama (2007)
10.1056/NEJMSR070105
The decrease in breast-cancer incidence in 2003 in the United States.
P. Ravdin (2007)
10.1001/ARCHOTOL.133.12.1258
Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma.
Hernán E González (2007)
10.1371/journal.pmed.0040069
Defective Awakening Response to Nocturnal Hypoglycemia in Patients with Type 1 Diabetes Mellitus
B. Schultes (2007)
10.1089/THY.2006.0202
Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules.
Sathya Subbiah (2007)
10.1016/J.JPEDS.2007.03.047
Continuous glucose monitoring in children with type 1 diabetes.
B. Buckingham (2007)
10.1016/J.AMJCARD.2006.10.064
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
A. Rossebø (2007)
10.4158/EP.13.1.11
Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance.
S. Rivers (2007)
10.1530/EJE-07-0189
Gamma knife stereotactic radiosurgery for acromegaly.
E. Vik-Mo (2007)
10.1016/J.SURONC.2007.05.004
Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
J. Lin (2007)
10.1210/JC.2007-0918
Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
A. Goldfine (2007)
10.1097/RMR.0b013e318572b76
Magnetic Resonance Imaging of Thyroid Cancer
Asako Miyakoshi (2007)
10.1016/J.AMJMED.2006.07.033
Impact of statin dosing intensity on transaminase and creatine kinase.
K. M. Dale (2007)
10.1056/NEJMOA062222
Dopamine agonists and the risk of cardiac-valve regurgitation.
R. Schade (2007)
10.1210/JC.2007-0378
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I.
W. Daughaday (2007)
10.1210/JC.2006-1587
Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance.
R. Pivonello (2007)
10.1007/s11102-007-0062-6
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly
L. Marinis (2007)
10.1038/ncponc0979
Radioactive iodine therapy in poorly differentiated thyroid cancer
R. M. Tuttle (2007)
10.1016/j.jacl.2007.10.001
LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.
W. Cromwell (2007)
10.1016/J.IJSU.2006.03.006
Serum calcium slope predicts hypocalcaemia following thyroid surgery.
S. Walsh (2007)
10.3171/JNS.2007.106.6.980
Gamma Knife surgery for Cushing's disease.
J. Jagannathan (2007)
10.1210/JC.2006-0993
Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.
R. Smallridge (2007)
10.1016/S0084-3741(08)70010-6
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes
L. Kennedy (2007)
10.1089/THY.2006.0234
Lung transplantation for pulmonary metastases and radiation-induced pulmonary fibrosis after radioactive iodine ablation of extensive lung metastases from papillary thyroid carcinoma.
James A. Lee (2007)
10.1046/j.1525-1497.2000.06289.x
End-of-life decision making
K. Rosenfeld (2007)
10.2337/db06-0738
Sulfonylurea Compounds Uncouple the Glucose Dependence of the Insulinotropic Effect of Glucagon-Like Peptide 1
J. de Heer (2007)
10.1056/NEJMSA073166
Adolescent overweight and future adult coronary heart disease.
K. Bibbins-Domingo (2007)
10.7326/0003-4819-147-6-200709180-00012
Glycemic Control and Type 2 Diabetes Mellitus: The Optimal Hemoglobin A1c Targets. A Guidance Statement from the American College of Physicians
A. Qaseem (2007)
10.1210/JC.2007-0075
Hypoglycemia due to an Insulin Binding Antibody in a Patient with an IgA-κ Myeloma
D. Halsall (2007)
10.1016/J.SURG.2007.08.012
The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.
K. Mccoy (2007)
10.1111/j.1365-2265.2007.02907.x
Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer
A. Iervasi (2007)
10.1210/JC.2006-2426
Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients.
M. Rickels (2007)
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
A. Shammas (2007)
10.2337/DIACLIN.25.2.50
Is There a Place for Insulin Pump Therapy in Your Practice
J. Skyler (2007)
10.1038/ncpendmet0499
Mechanisms of Disease: molecular genetics of childhood thyroid cancers
S. Yamashita (2007)
Differentiated thyroid cancer in children and adults: same or distinct disease?
B. Jarzab (2007)
10.1172/JCI30060
Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.
R. Temel (2007)
10.1016/J.AMJCARD.2006.11.018
Safety considerations with niacin therapy.
J. Guyton (2007)
10.1530/EJE-07-0088
Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer.
N. Cunha (2007)
10.1210/JC.2007-2260
Incretin hypersecretion in post-gastric bypass hypoglycemia--primary problem or red herring?
A. Vella (2007)
10.1056/NEJMOA071513
Estrogen therapy and coronary-artery calcification.
J. Manson (2007)
10.1210/JC.2006-0723
Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.
M. Schlumberger (2007)
10.2337/dc06-1789
A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events
A. Gangji (2007)
10.2337/dc06-1887
Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy
E. Mathiesen (2007)
10.1210/JC.2006-2573
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung.
M. Nauck (2007)
10.1507/ENDOCRJ.K06-100
Forty month follow-up of persistent and difficultly controlled acromegalic patients treated with depot long acting somatostatin analog octreotide.
D. Yetkin (2007)
10.1007/s00268-007-9312-z
Hereditary Non-medullary Thyroid Cancer
E. Kebebew (2007)
10.1590/S0004-27302007000500012
Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present.
Y. Demidchik (2007)
10.1385/ENDO:24:3:259
Neoplasia of the female reproductive tract
D. Archer (2007)
10.1210/JC.2006-2547
Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis.
P. Maison (2007)
10.1002/14651858.CD005613.PUB3
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
K. Horvath (2007)
10.1172/JCI30077
Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase.
S. Suh (2007)
10.1007/s00268-007-9405-8
Applicability of Intraoperative Parathyroid Hormone Assay During Total Thyroidectomy as a Guide for the Surgeon to Selective Parathyroid Tissue Autotransplantation
M. Barczyński (2007)
10.1016/J.SURG.2007.09.015
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
E. Mirallié (2007)
10.1111/J.1365-2125.2007.02959.X
Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.
S. Bonovas (2007)
10.1530/EJE-07-0109
Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism.
D. Vezzosi (2007)
10.1530/EJE.1.02340
Effect of transsphenoidal surgery on sleep apnoea in acromegaly.
L. Sze (2007)
10.3171/JNS.2007.106.5.833
Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission.
B. Pollock (2007)
10.1007/s10637-007-9091-2
A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer
A. Argiris (2007)
10.1210/JC.2007-0444
Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer.
S. Leboulleux (2007)
10.1056/NEJMOA0706201
Rosuvastatin in older patients with systolic heart failure.
J. Kjekshus (2007)
10.1016/J.DIABRES.2006.10.015
A review of human and analogue insulin trials.
S. Gough (2007)
10.7326/0003-4819-147-6-200709180-00178
Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus
S. Bolen (2007)
10.1007/s00125-007-0884-9
Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis
D. Golicki (2007)
10.1007/s11154-007-9062-0
Medical consequences of acromegaly: What are the effects of biochemical control?
A. Colao (2007)
Thyroid cancer in childhood: management
M Luster (2007)
Magnetic resonance imaging of thyroid cancer. Topics in magnetic resonance imaging
A Miyakoshi (2007)
Invited Commentary: US features of thyroid malignancy: pearls and pitfalls
J E Langer (2007)
Total thyroidectomy and adjuvant Page 56 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 80
D Handkiewicz-Junak (2007)
Total thyroidectomy and adjuvant
D Handkiewicz-Junak (2007)
Therapeutic impact of 18FDG-PET/CT in the management of iodinenegative recurrence of differentiated thyroid carcinoma. Surgery 142:952–958; discussion 952–958
E Mirallie (2007)
Thyroid cancer in children. Endocrinology and metabolism clinics of North America 36:779-806, vii
C Dinauer (2007)
Differentiated thyroid cancer in children and adults: same or distinct disease? Hormones (Athens) 6:200–209
B Jarzab (2007)
Total thyroidectomy and adjuvant Page 56 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y C tr F or D is ea se C on tr ol o n 04
D Handkiewicz-Junak (2007)
Thyroid cancer in childhood: management strategy, 752 FRANCIS ET AL. including dosimetry and long-term results. Hormones (Athens) 6:269–278
M Luster (2007)
10.1016/j.ecl.2007.12.003
Sonographic imaging of thyroid nodules and cervical lymph nodes.
S. Fish (2008)
10.1161/CIRCULATIONAHA.108.776823
Hot Flashes and Subclinical Cardiovascular Disease: Findings From the Study of Women’s Health Across the Nation Heart Study
R. Thurston (2008)
10.1530/EJE-08-0267
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.
I. Holdaway (2008)
10.1210/JC.2007-1154
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
A. P. Brown (2008)
10.1210/jc.2008-0299
Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy.
A. Colao (2008)
10.1016/j.soncn.2008.05.003
Theories underlying health promotion interventions among cancer survivors.
B. Pinto (2008)
10.1007/s00259-008-0883-1
Guidelines for radioiodine therapy of differentiated thyroid cancer
M. Luster (2008)
10.1097/01.JCN.0000305061.88624.fc
High-Dose Statin Therapy for Secondary Prevention of Stroke: Stroke Prevention by Aggressive Reduction in Cholesterol Levels Study Review
D. Schwertz (2008)
10.1016/j.atherosclerosis.2008.06.003
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
Y. Saitō (2008)
10.1016/j.atherosclerosis.2008.02.009
Recommendations for the use of LDL apheresis.
G. Thompson (2008)
10.1210/jc.2007-2283
Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant.
N. Goldenberg (2008)
10.1210/JC.2007-1404
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.
M. Castagna (2008)
10.1007/S11916-008-0014-5
Chronic headache and pituitary tumors
M. Levy (2008)
10.1007/s11102-008-0088-4
Hypopituitarism following radiotherapy
K. Darzy (2008)
10.1016/j.neurobiolaging.2006.09.001
Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: A possible window of opportunity effect
C. Lord (2008)
10.1097/gme.0b013e31805c08dc
Psychoeducational interventions to alleviate hot flashes: a systematic review
A. Tremblay (2008)
10.1067/j.cpsurg.2007.12.010
Recent advances in thyroid cancer.
E. Grubbs (2008)
10.1001/jama.299.9.1036
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
G. Heiss (2008)
10.1210/jc.2007-2357
Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer.
R. Kloos (2008)
10.1016/j.amjcard.2008.02.039
Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
B. G. Brown (2008)
10.1056/NEJMoa0806182
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
K. Jamerson (2008)
10.1007/s00268-008-9742-2
Risk Factors for Lateral Cervical Lymph Node Involvement in Follicular Thyroid Carcinoma
H. Alfalah (2008)
10.1210/jc.2008-0833
Lipodystrophy in patients with acromegaly receiving pegvisomant.
V. Bonert (2008)
10.1056/NEJMoa070716
Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
F. Brunkhorst (2008)
10.1016/S0140-6736(08)60104-X
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
P. Kearney (2008)
10.1056/NEJMoa0807646
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
P. Ridker (2008)
10.1016/J.ECL.2005.04.007
Thyroid nodules and cancers in children.
J. Josefson (2008)
10.1210/jc.2008-0660
Clinical and economic outcomes of thyroid and parathyroid surgery in children.
J. Sosa (2008)
10.1530/EJE-08-0306
Clinical use of cabergoline as primary and adjunctive treatment for acromegaly.
V. Moyes (2008)
10.1016/j.jacl.2007.12.006
Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice.
A. Sniderman (2008)
10.1016/j.ghir.2008.02.001
Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR.
E. O. Machado (2008)
10.1210/jc.2007-2084
Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index.
A. Arafat (2008)
10.2967/jnumed.107.046599
Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies
J. Garsi (2008)
10.1507/ENDOCRJ.K07E-125
Improvement of endothelial dysfunction in acromegaly after transsphenoidal surgery.
Haruna Sakai (2008)
10.1016/J.HUMPATH.2007.09.010
Adult diffuse nesidioblastosis: genetically or environmentally induced?
G. Klöppel (2008)
10.2337/dc08-0109
Standards of Medical Care in Diabetes—2008
J. M. Dora (2008)
10.1016/S0140-6736(08)61240-4
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Gissi-Hf Investigators (2008)
10.1097/SLA.0b013e31815792ed
Improved Contemporary Surgical Management of Insulinomas: A 25-year Experience at the Massachusetts General Hospital
M. Nikfarjam (2008)
10.1016/j.surg.2008.08.033
Pediatric endocrine surgery: who is operating on our children?
C. Tuggle (2008)
10.1210/jc.2008-0791
Prevalence of vertebral fractures in men with acromegaly.
G. Mazziotti (2008)
10.1016/j.amjcard.2008.02.056
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.
Zongliang Lu (2008)
10.2337/dc08-S061
Nutrition Recommendations and Interventions for Diabetes
J. Bantle (2008)
10.1677/ERC-08-0080
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
M. Capezzone (2008)
10.2967/jnumed.107.049072
Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal
R. M. Tuttle (2008)
10.1001/archinte.168.15.1617
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).
R. Wildman (2008)
10.1210/jc.2008-1528
Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series.
E. Brignardello (2008)
10.1111/j.1463-1326.2008.00967.x
Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single‐dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
M. R. Lankisch (2008)
10.1016/j.surg.2008.07.021
Is nodule size an independent predictor of thyroid malignancy?
C. McHenry (2008)
10.2337/dc08-s227
Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes
P. Rossetti (2008)
10.1089/dia.2008.0016
Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM).
I. Hirsch (2008)
10.2337/db07-1618
Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited
J. Lachin (2008)
10.1530/EJE-07-0838
Impact of musculoskeletal disease on quality of life in long-standing acromegaly.
A. Miller (2008)
10.1016/S0140-6736(08)61242-8
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S Yusuf (2008)
10.1634/theoncologist.2007-0212
Management of the solitary thyroid nodule.
Meei J. Yeung (2008)
10.2337/dc08-9018
Lipoprotein Management in Patients With Cardiometabolic Risk
J. Brunzell (2008)
10.1111/j.1365-2265.2007.03081.x
A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors
A. Sawka (2008)
10.1016/j.jacc.2008.08.039
Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
E. Mills (2008)
10.1515/JPEM.2008.21.4.323
Growth Hormone (GH) Treatment Does Not Restore Endothelial Function in Children with GH Deficiency
R. Hoffman (2008)
10.1111/j.1365-2265.2008.03222.x
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors
Anna M. Sawka (2008)
10.1530/EJE-08-0442
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease.
M. Davi’ (2008)
10.1016/j.ahj.2008.07.023
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
C. Cannon (2008)
10.1210/jc.2008-0962
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
W. Kim (2008)
10.1001/archpedi.162.6.526
Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis.
A. Corrias (2008)
10.1210/jc.2008-0027
A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly.
R. Murray (2008)
10.1016/j.jacc.2007.11.072
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
J. Shepherd (2008)
10.1007/s11102-008-0104-8
Alterations in body composition in acromegaly
L. Katznelson (2008)
10.1002/dc.20830
Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference
Z. Baloch (2008)
10.1007/s00268-008-9545-5
Evidence for the Role of Perioperative PTH Measurement after Total Thyroidectomy as a Predictor of Hypocalcemia
S. Grodski (2008)
10.1007/s00259-008-0761-x
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
M. Lassmann (2008)
10.1016/j.ecl.2008.02.004
Intragenic mutations in thyroid cancer.
M. Sobrinho-Simões (2008)
10.1016/j.amjcard.2007.08.033
Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis.
F. Messerli (2008)
10.1056/NEJMoa0802987
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
A. Patel (2008)
carci - noma : results of a study on 1087 patients and review of the literature
SA Fish (2008)
Intragenic mutations in thyroid cancer. Endocrinology and metabolism clinics of North America 37:333-362, viii
M Sobrinho-Simoes (2008)
Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nature clinical practice Endocrinology & metabolism 4:223-233
CA Spencer (2008)
Familial nonmedullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocrine-related cancer
M Capezzone (2008)
Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
CA Spencer (2008)
Clinical and economic outcomes of thyroid and parathyroid surgery in children. The Journal of clinical endocrinology and metabolism 93:3058-3065
JA Sosa (2008)
F18-fluorodeoxyglucosepositron emission tomography/computed tomography screening in Li-Fraumeni syndrome
S Masciari (2008)
10.1210/jc.2009-0593
Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.
M. Luster (2009)
10.1111/j.1445-2197.2009.04895.x
Management of hyperfunctioning single thyroid nodules in the era of minimally invasive thyroid surgery
C. Tan (2009)
10.1056/NEJMoa0808431
Glucose control and vascular complications in veterans with type 2 diabetes.
W. Duckworth (2009)
10.1001/archsurg.2009.116
Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger.
S. Pinchot (2009)
10.1007/s00259-009-1303-x
Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
F. Verburg (2009)
10.1016/j.jpeds.2008.12.019
Autonomous thyroid adenoma: only an adulthood disease?
K. Schwab (2009)
10.1097/HJH.0b013e32832d7370
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study
P. Sleight (2009)
10.1210/jc.2008-2671
Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly.
T. Wexler (2009)
10.1016/j.atherosclerosis.2008.09.026
Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
R. Rosenson (2009)
10.1530/EJE-08-0843
Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients.
S. Neggers (2009)
10.1016/j.maturitas.2009.01.004
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone.
M. Hellgren (2009)
10.1097/SLA.0b013e3181a77b7b
Follicular Thyroid Carcinoma in an Iodine-Replete Endemic Goiter Region: A Prospectively Collected, Retrospectively Analyzed Clinical Trial
R. Asari (2009)
10.1200/JCO.2008.21.1920
Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
A. Meadows (2009)
10.2337/dc09-0228
Adherence to the DASH Diet Is Inversely Associated With Incidence of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study
A. Liese (2009)
10.1007/BF03345774
Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy
E. Ghigo (2009)
10.1016/S0084-3954(08)79075-4
F18-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome
J. Stockman (2009)
10.2967/jnumed.109.066738
124I PET-Based 3D-RD Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison
R. Hobbs (2009)
10.1056/NEJMoa0808400
Renal and retinal effects of enalapril and losartan in type 1 diabetes.
M. Mauer (2009)
10.1016/j.jpeds.2008.11.059
Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents.
L. Lazar (2009)
10.1111/j.1365-2265.2008.03317.x
Postoperative PTH measurement facilitates day 1 discharge after total thyroidectomy
S. Grodski (2009)
10.1186/1472-6823-9-20
Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation
D. Moore (2009)
10.1089/thy.2009.0274
The Bethesda System for Reporting Thyroid Cytopathology.
E. Cibas (2009)
10.1210/jc.2008-2627
Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-month study.
A. Colao (2009)
10.1210/jc.2008-2333
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.
J. Bertherat (2009)
10.6004/JNCCN.2009.0075
NCCN task force: clinical utility of PET in a variety of tumor types.
D. Podoloff (2009)
10.1089/thy.2008.0429
The successful use of sorafenib to treat pediatric papillary thyroid carcinoma.
S. Waguespack (2009)
10.1080/09513590802485038
The role of estrogen receptor subtypes for vascular maintenance
L. Luksha (2009)
10.1210/jc.2008-2830
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between recombinant human thyrotropin stimulation and prolonged levothyroxine withdrawal.
A. Frigo (2009)
10.1016/j.jss.2009.03.088
Outcomes of surgically managed pediatric thyroid cancer.
Anna E Bargren (2009)
10.1080/13697130903006837
Hormone therapy and risk of venous thromboembolism among postmenopausal women
M. Canonico (2009)
10.1016/S0140-6736(09)61375-1
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
A. Astrup (2009)
10.1016/J.JVS.2008.11.115
Ten-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
R. Holman (2009)
10.1007/s00259-009-1368-6
Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer
C. Ma (2009)
10.1089/thy.2009.0159
Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.
S. Carty (2009)
10.1089/thy.2009.0110
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
D. Cooper (2009)
10.1056/NEJMoa0810177
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
B. Fellström (2009)
10.1212/01.wnl.0000339037.76336.cf
Postmenopausal hormone therapy and regional brain volumes
S. Resnick (2009)
10.1016/S0140-6736(08)61930-3
De testimonio: on the evidence for decisions about the use of therapeutic interventions
M. Rawlins (2009)
10.1016/j.cpr.2009.02.001
Review of Motivational Interviewing in promoting health behaviors.
R. K. Martins (2009)
10.1016/j.jpedsurg.2009.07.022
Pediatric thyroid fine-needle aspiration cytology: a meta-analysis.
C. Stevens (2009)
10.1111/j.1464-5491.2008.02640.x
Is diabetes a coronary risk equivalent? Systematic review and meta‐analysis
U. Bulugahapitiya (2009)
10.1136/bmj.b2376
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
J. Brugts (2009)
10.1016/j.atherosclerosis.2008.09.023
Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithm.
K. Bainey (2009)
10.1677/ERC-08-0335
New therapeutic advances in the management of progressive thyroid cancer.
J. Woyach (2009)
10.1089/thy.2008.0238
The usual ultrasonographic features of thyroid cancer are less frequent in small tumors that develop after a long latent period after the Chernobyl radiation release accident.
V. Drozd (2009)
10.1016/j.amjcard.2008.10.029
Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
M. Tikkanen (2009)
10.1186/1471-2407-9-306
Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival
N. Wada (2009)
10.1089/thy.2008.0343
Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence.
Soe Naing (2009)
10.2214/AJR.09.2386
Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT.
Ji Soo Choi (2009)
10.1016/j.suc.2009.06.010
Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues.
P. Angelos (2009)
10.1097/SLA.0b013e3181b3adab
Ipsilateral Versus Bilateral Central Neck Lymph Node Dissection in Papillary Thyroid Carcinoma
T. Moo (2009)
10.1097/MNM.0b013e32832dcfa7
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
Meng-Jie Dong (2009)
10.1097/gme.0b013e3181a4866b
Vasomotor symptoms and mortality: the Rancho Bernardo Study
J. Svartberg (2009)
10.1089/thy.2008.0392
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
A. Sawka (2009)
10.1016/j.jss.2009.03.098
Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients.
A. Hogan (2009)
10.1007/s11102-009-0186-y
Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly
A. A. van der Klaauw (2009)
10.4158/EP.15.6.540
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
H. Rodbard (2009)
10.1007/s11102-009-0207-x
Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
R. Salvatori (2009)
10.1111/j.1469-7580.2008.01035.x
Insulin and the IGF system in the human placenta of normal and diabetic pregnancies
U. Hiden (2009)
10.1111/j.1365-2362.2009.02163.x
Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia
D. Masuda (2009)
10.1080/13697130902986385
Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging
T. Simoncini (2009)
10.1007/s00268-009-0364-0
Long-Term Outcome in 215 Children and Adolescents with Papillary Thyroid Cancer Treated During 1940 Through 2008
I. Hay (2009)
10.1080/13697130902905757
Different cardiovascular effects of progestins according to structure and activity
A. Nath (2009)
10.1373/clinchem.2008.118356
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.
J. Contois (2009)
10.1245/s10434-009-0673-4
Treatment Strategy of Papillary Thyroid Carcinoma in Children and Adolescents: Clinical Significance of the Initial Nodal Manifestation
PhD Nobuyuki Wada MD (2009)
10.1159/000325406
A Quality Control Study on Cytotechnologist-Cytopathologist Concordance and Its Relationship to the Number of Dots on the Slide
M. Bongiovanni (2009)
10.1089/thy.2009.0073
Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young.
J. Koo (2009)
10.1016/j.atherosclerosis.2009.03.029
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS).
S. Oikawa (2009)
10.2214/AJR.08.1820
Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone?
J. Bonavita (2009)
10.2967/jnumed.108.061382
Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
R. Grewal (2009)
10.1530/EJE-09-0372
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial.
A. Giustina (2009)
10.1016/S0140-6736(09)60697-8
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
K. Ray (2009)
10.1530/EJE-09-0222
Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments.
C. Ronchi (2009)
10.1002/hed.21079
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma
G. Clayman (2009)
10.1089/thy.2009.0058
Ultrasound-guided fine-needle aspiration in the management of thyroid nodules in children and adolescents.
R. Izquierdo (2009)
10.1097/AOG.0b013e3181b6f268
Effect of Hot Flushes on Vascular Function: A Randomized Controlled Trial
P. Tuomikoski (2009)
10.1097/ANA.0b013e3181993719
Postoperative management of obstructive sleep apnea after transsphenoidal pituitary surgery.
L. Venkatraghavan (2009)
10.1210/jc.2008-1415
Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections.
M. Fatourechi (2009)
10.1089/thy.2009.0236
Protecting thyroid cancer patients from untoward effects of radioactive iodine treatment.
R. Kloos (2009)
10.3322/caac.20014
Thyroid Aspiration Cytology: Current Status
L. Layfield (2009)
10.1097/EJA.0b013e32831bc6fb
Intubation in patients with acromegaly: experience in more than 800 patients.
Z. Khan (2009)
10.1161/CIRCULATIONAHA.109.192216
American Heart Association Childhood Obesity Research Summit Report.
S. Daniels (2009)
10.2214/AJR.07.3731
Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the sixth edition of the AJCC/UICC TNM classification system.
J. Park (2009)
who receive radioactive iodine therapy
AM Sawka (2009)
Protecting
RT Kloos (2009)
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis. Nuclear medicine communications 30:639-650
MJ Dong (2009)
Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues. The Surgical clinics of North America 89:1157-1169
P Angelos (2009)
10.1007/s00259-010-1669-9
Favourable course of disease after incomplete remission on 131I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up
J. Biko (2010)
10.7326/0003-4819-152-8-201004200-00005
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
R. Glynn (2010)
10.2337/dc09-1444
Derivation and Validation of a New Cardiovascular Risk Score for People With Type 2 Diabetes
C. Elley (2010)
10.1016/j.jpeds.2010.04.026
Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior.
A. Machens (2010)
10.1530/EJE-09-1080
Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines.
D. Dworakowska (2010)
10.1136/bmj.b4909
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
D. Bonds (2010)
10.1016/J.AHJ.2010.08.012
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
A. Cass (2010)
10.2337/dc10-0494
Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial
Nicholas Jenkins (2010)
10.1111/j.1463-1326.2010.01232.x
Meta‐analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine
P. Home (2010)
10.1007/s11136-010-9696-3
The relationship between parental overprotection and health-related quality of life in pediatric cancer: the mediating role of perceived child vulnerability
S. Hullmann (2010)
10.1016/j.amjsurg.2010.03.009
Global variation in the pattern of differentiated thyroid cancer.
Stacey L Woodruff (2010)
10.1089/thy.2009.0386
Thyroid cancer in childhood: a retrospective review of childhood course.
C. O'Gorman (2010)
10.1016/j.surg.2010.03.021
Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit.
W. Shen (2010)
10.1089/thy.2009.0446
Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following ¹³¹I treatment: a systematic review.
M. Pawelczak (2010)
10.1002/hed.21373
Diminishing diagnosis of follicular thyroid carcinoma
K. Otto (2010)
10.1111/j.1463-1326.2009.01181.x
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
V. Fonseca (2010)
10.1210/jc.2009-1611
Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.
K. Miller (2010)
10.1016/j.beem.2010.07.003
Multiple endocrine neoplasia type 1 (MEN1).
R. Thakker (2010)
10.2165/11531380-000000000-00000
Resistance Training in the Treatment of the Metabolic Syndrome
B. Strasser (2010)
10.1016/j.jacc.2009.08.086
Asian Americans and cardiometabolic risk why and how to study them.
M. Jacob (2010)
10.1089/thy.2009.0338
Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer.
C. Spencer (2010)
10.1056/NEJMoa1001282
Effects of combination lipid therapy in type 2 diabetes mellitus.
H. Ginsberg (2010)
10.4158/EP.16.2.270
American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update.
J. Mechanick (2010)
10.1210/jc.2009-1912
Endocrine aspects of obstructive sleep apnea.
P. Attal (2010)
10.2165/11535380-000000000-00000
Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada
S. Tunis (2010)
10.2337/dc09-2009
Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
J. Gaziano (2010)
10.1210/jc.2009-2815
Female gonadal function before and after treatment of acromegaly.
M. Grynberg (2010)
10.4158/10024.GL
American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.
H. Gharib (2010)
10.1038/bmt.2009.309
Parental stress and perceived vulnerability at 5 and 10 years after pediatric SCT
C. M. J. Vrijmoet-Wiersma (2010)
10.4161/isl.2.2.10582
Facilitation of β-cell KATP channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac
C. Leech (2010)
10.1001/archinternmed.2010.182
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
K. Ray (2010)
10.1111/j.1538-7836.2010.03839.x
Hormone replacement therapy and the risk of venous thromboembolism: a population‐based study
C. Renoux (2010)
10.1530/EJE-09-0908
Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial.
Z. Mao (2010)
10.1210/jc.2010-0670
Approach to the patient with persistent acromegaly after pituitary surgery.
L. Katznelson (2010)
10.1016/j.amjcard.2009.12.051
Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy.
J. Kizer (2010)
10.1210/jc.2010-1500
Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values.
R. Kloos (2010)
10.1016/S0140-6736(10)60310-8
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
J. Armitage (2010)
10.1089/thy.2009.0266
Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma.
Libo Chen (2010)
10.1056/NEJMc1006407
Combination lipid therapy in type 2 diabetes.
F. Sacks (2010)
10.1159/000321841
Levothyroxine Treatment in Pediatric Benign Thyroid Nodules
A. Corrias (2010)
10.6004/JNCCN.2010.0095
Initial management and follow-up of differentiated thyroid cancer in children.
S. Waguespack (2010)
10.1016/S0084-3741(09)79430-2
Pediatric thyroid fine-needle aspiration cytology: a meta-analysis
E. Eugster (2010)
10.1210/er.2010-0003
Exposing the thyroid to radiation: a review of its current extent, risks, and implications.
B. Sinnott (2010)
10.1159/000320028
Pediatric Graves’ Disease: Controversies in Management
S. Rivkees (2010)
10.1161/CIRCULATIONAHA.109.865840
Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease
S. Costanzo (2010)
10.1056/NEJMoa1003795
Severe hypoglycemia and risks of vascular events and death.
S. Zoungas (2010)
10.1210/jc.2010-0394
Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly.
J. Leon-Carrion (2010)
10.1001/jama.2010.1500
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
R. Chlebowski (2010)
10.1111/j.1751-7141.2009.00059.x
Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis.
R. N. Bukkapatnam (2010)
10.1016/j.clon.2010.03.014
Cytotoxic chemotherapy for differentiated thyroid carcinoma.
S. Sherman (2010)
10.6004/JNCCN.2010.0094
Complications of radioactive iodine treatment of thyroid carcinoma.
Stephanie L. Lee (2010)
10.1016/S0140-6736(10)61350-5
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C. Baigent (2010)
Estrogen Receptors α and β Immunohistochemical Expression: Clinicopathological Correlations in Pituitary Adenomas
B. Manoranjan (2010)
10.1056/NEJMoa1001286
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
W. Cushman (2010)
10.1111/j.1365-2265.2009.03693.x
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using 18F‐FDG PET/CT
J. H. Seo (2010)
10.1245/s10434-010-1083-3
Utilization of Total Thyroidectomy for Differentiated Thyroid Cancer in Children
M. Raval (2010)
10.1210/jc.2009-2331
Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
P. Caron (2010)
10.1210/jc.2009-1567
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
W. Kim (2010)
10.1002/ijc.24738
A case‐control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well
Heli K. Lyytinen (2010)
10.1210/jc.2009-1239
Tumor volume of growth hormone-secreting pituitary adenomas during treatment with pegvisomant: a prospective multicenter study.
J. Buhk (2010)
10.1001/jama.2010.405
Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes.
O. Phung (2010)
10.1089/thy.2009.0466
Salivary gland malignancy and radioiodine therapy for thyroid cancer.
J. Klubo-Gwiezdzinska (2010)
10.3109/13697130902943287
Endothelial function and cardiovascular risk stratification in menopausal women
S. Mulvagh (2010)
10.1245/s10434-010-1102-4
Clinical and Pathological Factors Related to 18F-FDG-PET Positivity in the Diagnosis of Recurrence and/or Metastasis in Patients with Differentiated Thyroid Cancer
DipSci MBChB Dch Fracp MM Kevin London BHB (2010)
MRI versus (1)(3)(1)I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma
J Mihailovic (2010)
MRI versus 131I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma
J Mihailovic (2010)
Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior. The Journal of pediatrics 157:648-652
A Machens (2010)
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT. Clinical endocrinology 72:558-563
JH Seo (2010)
Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experience. European journal of nuclear medicine and molecular imaging 37:896-903
FA Verburg (2010)
Trotti A (eds) AJCC Cancer Staging Manual
SB Thyroid. In Edge (2010)
Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during
ID Hay (2010)
10.4158/EP10334.CR
Hürthle cell thyroid carcinoma presenting as a "hot" nodule.
Yalla Nm (2011)
10.1089/thy.2010.0355
Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
A. Miyauchi (2011)
10.1111/j.1532-5415.2011.03721.x
Angiotensin‐Converting Enzyme Inhibitor and Statin Use and Incident Mobility Limitation in Community‐Dwelling Older Adults: The Health, Aging and Body Composition Study
Shelly L. Gray (2011)
10.1177/193229681100500630
Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes
D. Klonoff (2011)
10.1002/cncr.26045
Oncofertility and preservation of reproductive capacity in children and young adults
W. Wallace (2011)
10.1210/jc.2011-1740
Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
C. Spencer (2011)
10.1017/S1368980011002254
Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies
Jusheng Zheng (2011)
10.2174/138920211798120781
Employing Genetic Markers to Improve Diagnosis of Thyroid Tumor Fine Needle Biopsy
J. Cerutti (2011)
10.4158/EP10334.CR
Hürthle cell thyroid carcinoma presenting as a "hot" nodule.
N. Yalla (2011)
10.1038/modpathol.2010.133
Follicular thyroid carcinoma
M. Sobrinho-Simões (2011)
10.1210/er.2011-0011
The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.
S. Rivkees (2011)
10.1161/CIRCULATIONAHA.110.016337
Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials
S. Bangalore (2011)
10.1089/thy.2010.0353
Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma.
K. Sugino (2011)
10.7326/0003-4819-154-2-201101180-00300
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
J. Buse (2011)
10.1001/jama.2011.860
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.
D. Preiss (2011)
10.1007/s00125-011-2446-4
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso (2011)
The use of dosimetry in the treatment of differentiated thyroid cancer.
M. Lassmann (2011)
10.1089/thy.2011.0063
Papillary thyroid carcinoma in Peutz-Jeghers syndrome.
V. Triggiani (2011)
10.1210/jc.2010-2695
Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin.
P. Malandrino (2011)
10.1210/jc.2011-1469
Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
Y. Nikiforov (2011)
10.1002/lary.21227
Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer
Harry S. Hwang (2011)
10.1016/S0140-6736(11)60205-5
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
K. Gadde (2011)
10.1016/j.clinimag.2011.01.001
Suspiciously malignant findings on ultrasound after fine needle aspiration biopsy in a thyroid nodule with initially benign ultrasound and cytologic result: to repeat or to follow-up.
Yu-Mee Sohn (2011)
10.1097/gme.0b013e3181f9f7c3
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women
V. Olié (2011)
10.1001/archinternmed.2011.424
Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions.
T. Fried (2011)
10.1001/jama.2011.1139
Use of radioactive iodine for thyroid cancer.
M. Haymart (2011)
10.1111/j.1463-1326.2011.01459.x
Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof-of-concept’ study
D. Owens (2011)
10.1210/jc.2010-2443
Place of cabergoline in acromegaly: a meta-analysis.
Laure Sandret (2011)
10.1007/s12149-011-0545-4
Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
P. Bannas (2011)
10.1093/eurheartj/ehr305
Current concepts on coronary revascularization in diabetic patients.
M. Roffi (2011)
10.1016/j.jacc.2011.06.063
Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.
D. Mozaffarian (2011)
10.1002/jcb.23000
Metformin sensitizes insulin signaling through AMPK‐mediated pten down‐regulation in preadipocyte 3T3‐L1 cells
SOO KYUNG Lee (2011)
10.1002/cncr.26070
Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy
N. Iyer (2011)
10.1089/thy.2009.0406
Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study.
E. Robenshtok (2011)
10.1089/thy.2011.2111.com
Historical note: TSH suppression for thyroid cancer.
J. Hurley (2011)
10.1001/archinternmed.2011.32
Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention.
T. Fried (2011)
10.2337/dc11-0064
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
R. DeFronzo (2011)
10.1016/j.jacc.2011.02.014
Cardiac care for older adults. Time for a new paradigm.
D. Forman (2011)
10.1007/s00247-011-2039-x
SPECT/CT imaging in children with papillary thyroid carcinoma
H. Kim (2011)
10.1111/j.1532-5415.2011.03523.x
External Validation of an Index to Predict Up to 9‐Year Mortality of Community‐Dwelling Adults Aged 65 and Older
M. Schonberg (2011)
10.1089/thy.2011.0170
Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
G. Clayman (2011)
10.1016/j.clon.2011.01.160
The Chernobyl thyroid cancer experience: pathology.
V. Livolsi (2011)
10.1097/FJC.0b013e318202709f
Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
E. Bruckert (2011)
10.1089/thy.2010.0256
Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
W. Moses (2011)
10.1016/j.surg.2011.09.023
Predictive factors of malignancy in pediatric thyroid nodules.
Rashmi Roy (2011)
10.1016/j.jacl.2011.07.005
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
M. Davidson (2011)
10.1089/thy.2010.0365
Frequency of germline PTEN mutations in differentiated thyroid cancer.
R. Nagy (2011)
10.1111/j.1365-2265.2010.03949.x
Serum phosphate predicts temporary hypocalcaemia following thyroidectomy
A. Sam (2011)
10.3949/ccjm.78a.10073
Statin myopathy: A common dilemma not reflected in clinical trials
Genaro Fernandez (2011)
10.1111/j.1463-1326.2010.01306.x
Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review
C. Deacon (2011)
10.1002/hed.21492
Positron emission tomography and positron emission tomography‐CT evaluation for recurrent papillary thyroid carcinoma: Meta‐analysis and literature review
M. Miller (2011)
10.1210/jc.2011-1616
Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
J. Ngeow (2011)
10.1503/cmaj.101333
The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis
F. McAlister (2011)
10.1007/s00259-011-1788-y
Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level
H. Hänscheid (2011)
10.1210/jc.2010-0898
Approach to the pediatric patient with Graves' disease: when is definitive therapy warranted?
A. Bauer (2011)
10.1210/jc.2010-1315
Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.
Jessica R Smith (2011)
10.1001/archinternmed.2011.351
Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent.
N. Paynter (2011)
10.1038/ejhg.2011.20
Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model
J. Mester (2011)
10.1038/nrendo.2011.142
Molecular genetics and diagnosis of thyroid cancer
Y. Nikiforov (2011)
10.1634/theoncologist.2010-0405
Follicular adenoma and carcinoma of the thyroid gland.
C. McHenry (2011)
10.1111/j.1365-2265.2010.03898.x
Does an undetectable rhTSH‐stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
J. Klubo-Gwiezdzinska (2011)
10.1089/thy.2010.0403
Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
J. Sisson (2011)
10.1530/EJE-11-0156
Postablation (131)I scintigraphy with neck and thorax SPECT-CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer.
R. Ciappuccini (2011)
10.1038/sj.bjc.6605967
Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident
L. Zablotska (2011)
10.1210/jc.2010-2567
Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules.
C. Ferraz (2011)
10.1056/NEJMoa1107579
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
W. Boden (2011)
10.1016/j.jpedsurg.2010.09.009
Thyroid surgery at Children's Hospital Boston: a 35-year single-institution experience.
S. Scholz (2011)
10.1007/s00259-011-1841-x
Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl
H. Hebestreit (2011)
Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. The Journal of clinical endocrinology and metabolism 96:2016-2026
C Ferraz (2011)
Suspiciously malignant findings on ultrasound after fine ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER 749 D ow nl oa de d by
YM Sohn (2011)
Use of radioactive iodine for thyroid cancer. JAMA 306:721-728. Page 70 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 80
MR Haymart (2011)
Rising incidence of second cancers in patients with low - risk ( T 1 N 0 )
NG Iyer (2011)
Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC). The Journal of clinical endocrinology and metabolism 96:3615-3627
CA Spencer (2011)
Suspiciously malignant findings on ultrasound after fine ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER
YM Sohn (2011)
The comparison of (131)I whole-body scans on the third and tenth day after (131)I therapy in patients with well-differentiated thyroid cancer: preliminary report
JW Lee (2011)
Radiation safety in the treatment of patients with thyroid diseases by radioiodine Page 72 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 80
JC Sisson (2011)
10.1007/s00259-012-2310-x
Value of 131I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature
Yan-li Xue (2012)
10.3748/wjg.v18.i14.1642
Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis.
C. Naing (2012)
10.1111/j.1532-5415.2011.03867.x
All‐Cause 1‐, 5‐, and 10‐Year Mortality in Elderly People According to Activities of Daily Living Stage
M. Stineman (2012)
10.1002/cncy.21199
Cytomorphological and molecular genetic findings in pediatric thyroid fine‐needle aspiration
S. Monaco (2012)
10.1089/thy.2012.0051
Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
K. Sugino (2012)
10.1530/EJE-12-0105
Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma.
C. Buffet (2012)
10.3389/fendo.2012.00061
Familial Follicular Cell-Derived Thyroid Carcinoma
E. Son (2012)
10.1016/j.surg.2012.08.056
Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy.
L. Morris (2012)
10.1089/thy.2011.0322
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment.
Ji Min Han (2012)
10.1038/ki.2011.415
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.
F. Ismail-Beigi (2012)
10.1210/jc.2012-1823
Quality of life and anxiety in adolescents with differentiated thyroid cancer.
A. Oren (2012)
10.1056/NEJMoa1203208
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
E. Alexander (2012)
10.1016/j.amjcard.2012.04.061
Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus.
Harshal R. Patil (2012)
10.1210/JC.2012-1123
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?
C. Durante (2012)
10.1056/NEJMoa1203858
Basal insulin and cardiovascular and other outcomes in dysglycemia.
H. Gerstein (2012)
10.1097/MED.0b013e328357fa0c
Radioactive iodine therapy
Stephanie L. Lee (2012)
10.1089/thy.2011.0192
In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
H. Mazeh (2012)
10.1007/s11606-012-2103-8
Effect of Exercise on Blood Pressure in Type 2 Diabetes: A Randomized Controlled Trial
D. Dobrosielski (2012)
10.1089/thy.2012.0183
Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence.
J. Hugo (2012)
10.1111/j.1463-1326.2012.01603.x
Glycaemic efficacy of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors as add‐on therapy to metformin in subjects with type 2 diabetes—a review and meta analysis
C. Deacon (2012)
10.1007/s00405-012-2205-2
The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview
G. Treglia (2012)
10.2337/dc11-1928
Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets
J. DeVries (2012)
10.1161/CIRCULATIONAHA.111.026567
Medical Therapy for the Patient With Obesity
G. Bray (2012)
10.1016/j.clcc.2012.01.006
The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized.
E. Steinhagen (2012)
10.1001/jama.2012.39
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
K. Flegal (2012)
10.1089/thy.2011.0349
Ultrasonographic screening for thyroid cancer in siblings of patients with apparently sporadic papillary carcinoma.
P. Rosário (2012)
10.1210/jc.2011-3017
Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.
A. Chindris (2012)
10.1210/jc.2012-3070
Quality of life in adolescent patients with differentiated thyroid cancer: moving beyond survival.
S. Mostoufi‐Moab (2012)
10.1016/S0140-6736(12)61190-8
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
P. Ridker (2012)
10.1097/MNM.0b013e3283550257
Role of SPECT/CT in differentiated thyroid cancer
T. Barwick (2012)
10.1089/thy.2011.0522
Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer.
R. Padovani (2012)
10.1016/j.jacc.2012.03.058
High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?
Emil M Degoma (2012)
10.1056/NEJMp1109283
Shared decision making--pinnacle of patient-centered care.
M. Barry (2012)
10.1210/jc.2012-1083
Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis.
D. Mcleod (2012)
10.1371/journal.pone.0033692
Achieving Secondary Prevention Low-Density Lipoprotein Particle Concentration Goals Using Lipoprotein Cholesterol-Based Data
Simon C. Mathews (2012)
10.1111/j.1532-5415.2011.03786.x
Age Patterns of Incidence of Geriatric Disease in the U.S. Elderly Population: Medicare‐Based Analysis
I. Akushevich (2012)
10.1016/S0140-6736(12)60367-5
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
B. Mihaylova (2012)
10.4158/EP.18.S1.1
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.
P. Jellinger (2012)
10.4158/EP12160.PS
American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine.
J. Mechanick (2012)
10.1089/thy.2012.0011
Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.
D. Giordano (2012)
10.1185/03007995.2012.665046
Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin
A. Barnett (2012)
10.1089/thy.2011.0139
Quality of life in patients with thyroid cancer compared with the general population.
S. Singer (2012)
10.1089/thy.2011.0020
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodin
P. Rosário (2012)
10.1056/NEJMoa1108586
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
M. Schlumberger (2012)
10.2174/157488412800958686
GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacy.
G. Derosa (2012)
10.3945/ajcn.111.024927
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study123
W. Garvey (2012)
10.4158/EP12065.RA
Overview of molecular biomarkers for enhancing the management of cytologically indeterminate thyroid nodules and thyroid cancer.
D. Duick (2012)
10.1007/s00125-012-2534-0
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. Inzucchi (2012)
carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation
TD Barwick (2012)
papillary cancer
PW Rosario (2012)
Quality of Life and Anxiety in Adolescents with Differentiated Thyroid Cancer. The Journal of clinical endocrinology and metabolism 97:E1933-1937
A Oren (2012)
cancer : a systematic review and meta - analysis
C Durante (2012)
Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response metaanalysis. The Journal of clinical endocrinology and metabolism 97:2682-2692
DS McLeod (2012)
Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy. Surgery 152:1165–1171
LF Morris (2012)
10.1159/000351029
Indeterminate Pediatric Thyroid Fine Needle Aspirations: A Study of 68 Cases
M. Smith (2013)
10.1089/thy.2013.0496
Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
C. Spencer (2013)
10.1016/j.jacc.2012.10.030
The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
Paul M. Lavigne (2013)
10.1210/jc.2012-4172
Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry.
A. Hoofnagle (2013)
10.1007/s00423-013-1140-z
Minimally invasive follicular thyroid cancer (MIFTC)—a consensus report of the European Society of Endocrine Surgeons (ESES)
G. Dionigi (2013)
10.1210/jc.2012-3042
Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
C. Currie (2013)
10.1530/EJE-13-0386
Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation.
C. Nascimento (2013)
10.1210/jc.2013-1059
Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
C. Reiners (2013)
10.1210/jc.2013-2259
Approach to the patient: role of dosimetric RAI Rx in children with DTC.
F. Verburg (2013)
10.2337/db12-0207
Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study)
Z. Zhou (2013)
10.1210/er.2012-1038
Evolving approaches to patients with advanced differentiated thyroid cancer.
B. Haugen (2013)
10.1111/dom.12064
Inhibition of the sodium glucose co‐transporter‐2: its beneficial action and potential combination therapy for type 2 diabetes mellitus
L. Chen (2013)
10.1530/ERC-13-0066
Differentiated thyroid carcinoma: defining new paradigms for postoperative management.
C. Durante (2013)
10.1186/1897-4287-11-13
Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals
S. Septer (2013)
10.1210/jc.2012-2909
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring.
Aubrey A. Carhill (2013)
10.1186/1741-7015-11-7
Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines
T. Yu (2013)
10.1089/thy.2012.0606
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
F. Verburg (2013)
10.1016/j.surg.2012.12.008
Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma.
Ji In Lee (2013)
10.1097/CCO.0b013e32835a9ab1
Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer
L. Giovanella (2013)
10.2146/ajhp110514
Canagliflozin, a new sodium-glucose cotransporter 2 inhibitor, in the treatment of diabetes.
S. Nisly (2013)
10.1016/j.jacc.2013.08.003
Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.
G. Gibbons (2013)
10.1093/jnci/djt277
Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
R. Pilarski (2013)
10.1371/journal.pone.0059709
Spectrum and Risk of Neoplasia in Werner Syndrome: A Systematic Review
J. Lauper (2013)
10.1016/j.ijporl.2013.07.029
Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules.
Melissa A Buryk (2013)
10.1159/000345676
Endocrine tumors associated with neurofibromatosis type 1, Peutz-Jeghers syndrome and other familial neoplasia syndromes.
Esra Kalkan (2013)
10.2337/dc12-0931
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
M. Hawa (2013)
10.1016/j.jacc.2013.05.019
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
C. Yancy (2013)
10.1007/s00268-013-2261-9
Thyroid Nodules (≥4 cm): Can Ultrasound and Cytology Reliably Exclude Cancer?
Laura I. Wharry (2013)
10.1371/journal.pone.0083220
Thyroid Ultrasound Findings in Children from Three Japanese Prefectures: Aomori, Yamanashi and Nagasaki
N. Hayashida (2013)
10.1002/14651858.CD004816.pub5
Statins for the primary prevention of cardiovascular disease.
F. Taylor (2013)
10.1093/eurheartj/eht055
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
R. Haynes (2013)
10.1210/jc.2013-1796
A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults.
A. Gupta (2013)
10.1016/j.jacc.2013.08.004
The next steps in developing clinical practice guidelines for prevention.
G. Gibbons (2013)
Cowden syndrome and the PTEN 748 FRANCIS ET AL. hamartoma tumor syndrome: systematic review and revised diagnostic criteria
R Pilarski (2013)
Cowden syndrome and the PTEN
R Pilarski (2013)
Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position paper. Thyroid 23:11901192
CA Spencer (2013)
Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position paper. Thyroid 23:1190–1192
CA Spencer (2013)
A standardized assessment of thyroid nodules in children confirms Page 57 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y C tr F or D is ea se C on tr ol o n 04
A Gupta (2013)
A standardized assessment of thyroid nodules in children confirms Page 57 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y
A Gupta (2013)
KAe. SEER Cancer Statistics Review, 1975-2010, based on November 2012 SEER data submission, posted to the SEER web
N Howlader (2013)
Differentiated thyroid carcinoma: defining new paradigms for postoperative management. Endocrine-related cancer 20:R141-154
C Durante (2013)
Value of (1)(3)(1)I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature. European journal of nuclear medicine and molecular imaging 40:768-778
YL Xue (2013)
10.1530/EJE-13-0623
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
T. Papathomas (2014)
10.1089/THY.2012.0468
Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
IyerPallavi (2014)
10.1016/j.jpeds.2014.01.059
Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study.
L. Vergamini (2014)
DICER1-Related Disorders
L. Doros (2014)
10.1016/S0140-6736(14)60421-9
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
M. Brose (2014)
10.1089/thy.2012.0468
Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
Pallavi Iyer (2014)
10.1089/thy.2013.0427
Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?
P. Rosário (2014)
10.1097/HP.0000000000000007
Tenth Warren K. Sinclair Keynote Address—The Fukushima Nuclear Power Plant Accident and Comprehensive Health Risk Management
S. Yamashita (2014)
10.1210/jc.2013-2617
Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic.
A. Kundel (2014)
10.1210/jc.2013-4206
Exploring the association Between DICER1 mutations and differentiated thyroid carcinoma.
L. de Kock (2014)
Sorafenib in radioactive iodinerefractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
MS Brose (2014)
Nonpheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCCPGL syndromes: a clinicopathological and molecular analysis
TG Papathomas (2014)
Nonpheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis
TG Papathomas (2014)
Calsolari MR 2014 Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin? Thyroid 24:533–536
PW Rosario (2014)
10.1155/2015/796471
Is Stimulated Thyroglobulin Necessary after Ablation in All Patients with Papillary Thyroid Carcinoma and Basal Thyroglobulin Detectable by a Second-Generation Assay?
P. Rosário (2015)
10.1056/NEJMoa1406470
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
M. Schlumberger (2015)
10.1530/ERC-15-0381
Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma?
M. I. V. Cordioli (2015)
10.1016/j.ijporl.2015.08.004
Conservative or radical surgery for pediatric papillary thyroid carcinoma: A systematic review of the literature.
X. Jin (2015)
10.1016/j.jpeds.2015.07.037
Evaluating the Rare and Predicting the Worst: Lessons for Thyroid Nodules.
S. Rivkees (2015)
10.1089/thy.2015.0275
Inaugural Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer: Children Are Not Small Adults.
S. Lafranchi (2015)
Grade Definitions
U. S. Preventive Services Task Force Ratings (2015)



This paper is referenced by
10.1007/s13193-021-01312-w
Factors Influencing Cervical Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancers
S. Qureshi (2021)
10.1007/s00383-021-04927-w
Association of same-day discharge with hospital readmission after pediatric thyroidectomy
Jasmine Bhinder (2021)
10.3390/cancers13164051
Laryngeal Neural Monitoring during Pediatric Thyroid Cancer Surgery—Is Transcartilage Recording a Preferable Method?
Tzu-Yen Huang (2021)
10.1007/978-3-030-61919-0_11
An Adolescent with Papillary Thyroid Carcinoma and Locally Metastatic Disease but No Distant Metastases
Sarah J. Bottomley (2021)
10.18203/ISSN.2454-5929.IJOHNS20211192
Management of benign paediatric thyroid nodules: experience from paediatric ENT services of a tertiary care hospital
A. Chakravarti (2021)
10.1007/978-3-030-63277-9_9
Levothyroxine and Cancer
T. Bednarczuk (2021)
10.14341/probl12750
[Clinical practice guidelines "Management of iodine deficiency disorders"].
F. М. Abdulkhabirova (2021)
10.3390/cancers13133123
Molecular Alterations in Relation to Histopathological Characteristics in a Large Series of Pediatric Papillary Thyroid Carcinoma from a Single Institution
E. Macerola (2021)
10.47102/ANNALS-ACADMEDSG.2020378
Prevalence of thyroid malignancy and hormonal dysfunction following radiation exposure in childhood.
Y. Tiong (2021)
10.1089/CT.2021;33.217-220
Understanding of Pulmonary Metastases in Pediatric Patients with Differentiated Thyroid Cancer Is Evolving
Kara D Meister (2021)
10.1111/cen.14457
Recombinant human thyroid‐stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults
Max A Schumm (2021)
10.24911/PJNMED.175-1598982543
Radioactive Iodine uptake in the breast tissue of Nulliparous adolescent girls and young women
A. Sher (2021)
10.3390/cancers13133293
Comparison of Surgical Outcomes between Robotic Transaxillary and Conventional Open Thyroidectomy in Pediatric Thyroid Cancer
In A Lee (2021)
10.1016/j.ijscr.2021.106315
Co-occurrence of bilateral intrathyroidal parathyroid gland and papillary thyroid carcinoma; a case report
Ari M. Abdullah (2021)
10.1007/s00247-021-05083-y
Employing caution when applying the American College of Radiology Thyroid Imaging Reporting and Data System for pediatric thyroid nodule management
Marla B. K. Sammer (2021)
10.21608/MJCU.2021.167848
Incidence of Recurrent Differentiated Thyroid Carcinoma in Paediatrics and Adolescents after Thyroid Surgery: A Meta-Analysis Study of Last 20 Years
M. B. A. M. AYMAN A. ALBAGHDADY, M.D. (2021)
10.1186/s13633-020-00084-4
A synchronous papillary and follicular thyroid carcinoma presenting as a large toxic nodule in a female adolescent
J. Van Vlaenderen (2020)
10.1016/j.clon.2020.11.007
Paediatric Molecular Radiotherapy: Challenges and Opportunities.
M. Aldridge (2020)
10.1016/j.amjsurg.2020.03.025
Outpatient thyroidectomy in the pediatric population.
Sophie Dream (2020)
10.1515/jpem-2020-0174
BRAF V600E and TERT promoter mutations in paediatric and young adult papillary thyroid cancer and clinicopathological correlation
D. Chakraborty (2020)
10.1007/s13139-020-00643-w
Reduction of Salivary Gland Damage During Radioiodine Therapy for Differentiated Thyroid Cancers
B. Ahn (2020)
10.5144/0256-4947.2020.316
Thyroid surgery in 103 children in a single institution from 2000-2014
O. Almosallam (2020)
10.1002/lary.28937
Patterns and Predictors of Metastatic Spread to the Neck in Pediatric Thyroid Carcinoma
E. Propst (2020)
10.1159/000511140
A Japanese Family with DICER1 Syndrome Found in Childhood-Onset Multinodular Goitre
K. Nagasaki (2020)
Thyroid Uptake and Scan
A. Iqbal (2020)
10.1055/s-0040-1703013
Current Image-Guided Interventions in Pediatric Surgery.
Nathan S. Rubalcava (2020)
10.15406/EMIJ.2020.08.00270
A case series and review on pediatric thyroid nodules
Anju P Sukumaran (2020)
10.1007/s12020-020-02379-1
Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer
M. Klain (2020)
10.1007/s00268-020-05641-9
Invited Commentary: Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30-Year Experience at the Single Institution
Danielle I Ellis (2020)
10.1007/s00247-019-04602-2
Pediatric thyroid ultrasound: a radiologist’s checklist
I. Tritou (2020)
10.1007/978-3-030-52984-0_24
Thyroid Disorders in Adolescence
Esra Karslioglu-French (2020)
10.1007/s00268-020-05598-9
Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30-Year Experience at a Single Institution
Kwangsoo Kim (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar